Published Articles

Numerous peer review articles reflect the high-quality research activity of the Buffalo Neuroimaging Analysis Center (BNAC), and to date, the BNAC has contributed more than 450 articles to the field of neuroimaging and neuroscience. Furthermore, BNAC research projects have involved international collaboration with a variety of clinicians and scientists pursuing the use of quantitative MRI to study brain disorders.

2020

  • Jacobsen C, Zivadinov R, Myhr KM, Dalaker TO, Dalen I, Bergsland N and Farbu E (2020). "Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study." Mult Scler J Exp Transl Clin 6(1): 2055217320902481. [Open article]
  • Jakimovski D, Zivadinov R, Weinstock-Guttman B, Bergsland N, Dwyer MG and Lagana MM (2020). "Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy." Fluids Barriers CNS 17(1): 9. [Open article]
  • Jakimovski D, Weinstock-Guttman B, Ramanathan M, Dwyer MG and Zivadinov R (2020). "Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective." Vaccines (Basel) 8(1). [Open article]
  • Benedict RH, Pol J, Yasin F, Hojnacki D, Kolb C, Eckert S, Tacca B, Drake A, Wojcik C, Morrow SA, Jakimovski D, Fuchs TA, Dwyer MG, Zivadinov R and Weinstock-Guttman B (2020). "Recovery of cognitive function after relapse in multiple sclerosis." Mult Scler: 1352458519898108. [Open article]
  • Murali N, Browne RW, Fellows Maxwell K, Bodziak ML, Jakimovski D, Hagemeier J, Bergsland N, Weinstock-Guttman B, Zivadinov R and Ramanathan M (2020). "Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 years of follow-up." Eur J Neurol 27(1): 188-e184. [Open article]
  • Vaughn CB, Kavak KS, Dwyer MG, Bushra A, Nadeem M, Cookfair DL, Ramanathan M, Benedict RH, Zivadinov R, Goodman A, Krupp L, Motl RW, Weinstock-Guttman B and New York State Multiple Sclerosis C (2020). "Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium." Mult Scler 26(1): 99-108. [Open article]
  • Ziliotto N, Zivadinov R, Baroni M, Marchetti G, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Straudi S, Manfredini F, Ramanathan M and Bernardi F (2020). "Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis." Eur J Neurol 27(2): 235-243. [Open article]

2019

  • Jakimovski D, Zivadinov R, Pelizzari L, Browne RW, Weinstock-Guttman B and Ramanathan M (2019). "Lipoprotein(a) Levels Are Associated with the Size of Extracranial Arteries in Multiple Sclerosis." J Vasc Res: 1-8. [Open article]
  • Dwyer MG, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Barnett MH, Wang C, Tomic D, Silva D and Zivadinov R (2019). "Salient Central Lesion Volume: A Standardized Novel Fully Automated Proxy for Brain FLAIR Lesion Volume in Multiple Sclerosis." J Neuroimaging 29(5): 615-623. [Open article]
  • Fuchs TA, Ziccardi S, Dwyer MG, Charvet LE, Bartnik A, Campbell R, Escobar J, Hojnacki D, Kolb C, Oship D, Pol J, Shaw MT, Wojcik C, Yasin F, Weinstock-Guttman B, Zivadinov R and Benedict RHB (2019). "Response heterogeneity to home-based restorative cognitive rehabilitation in multiple sclerosis: An exploratory study." Mult Scler Relat Disord 34: 103-111. [Open article]
  • Jakimovski D, Kuhle J, Ramanathan M, Barro C, Tomic D, Hagemeier J, Kropshofer H, Bergsland N, Leppert D, Dwyer MG, Michalak Z, Benedict RHB, Weinstock-Guttman B and Zivadinov R (2019). "Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study." Ann Clin Transl Neurol 6(9): 1757-1770. [Open article]
  • Karthikeyan B, Sonkawade SD, Pokharel S, Preda M, Schweser F, Zivadinov R, Kim M and Sharma UC (2019). "Tagged cine magnetic resonance imaging to quantify regional mechanical changes after acute myocardial infarction." Magn Reson Imaging. [Open article]
  • Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D, Kropshofer H, Fuchs TA, Barro C, Leppert D, Yaldizli O, Kuhle J and Benedict RH (2019). "Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study." Mult Scler: 1352458519881428. [Open article]
  • Schweser F, Kyyriainen J, Preda M, Pitkanen A, Toffolo K, Poulsen A, Donahue K, Levy B and Poulsen D (2019). "Visualization of thalamic calcium influx with quantitative susceptibility mapping as a potential imaging biomarker for repeated mild traumatic brain injury." Neuroimage 200: 250-258. [Open article]
  • Tavazzi E, Bergsland N, Kuhle J, Jakimovski D, Ramanathan M, Maceski AM, Tomic D, Hagemeier J, Kropshofer H, Leppert D, Dwyer MG, Weinstock-Guttman B, Benedict RHB and Zivadinov R (2019). "A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis." J Neurol. [Open article]
  • Bergsland N, Tavazzi E, Schweser F, Jakimovski D, Hagemeier J, Dwyer MG and Zivadinov R (2019). "Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders." CNS Drugs 33(11): 1073-1086. [Open article]
  • Genovese AV, Hagemeier J, Bergsland N, Jakimovski D, Dwyer MG, Ramasamy DP, Lizarraga AA, Hojnacki D, Kolb C, Weinstock-Guttman B and Zivadinov R (2019). "Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis." Radiology 293(2): 424-433. [Open article]
  • Zivadinov R, Ramanathan M, Hagemeier J, Bergsland N, Ramasamy DP, Durfee J, Kolb C and Weinstock-Guttman B (2019). "Teriflunomide's effect on humoral response to Epstein-Barr virus and development of cortical gray matter pathology in multiple sclerosis." Mult Scler Relat Disord 36: 101388. [Open article]
  • Jakimovski D, Topolski M, Genovese AV, Weinstock-Guttman B and Zivadinov R (2019). "Vascular aspects of multiple sclerosis: emphasis on perfusion and cardiovascular comorbidities." Expert Rev Neurother 19(5): 445-458. [Open article]
  • Moore JJ, Massey JC, Ford CD, Khoo ML, Zaunders JJ, Hendrawan K, Barnett Y, Barnett MH, Kyle KA, Zivadinov R, Ma KC, Milliken ST, Sutton IJ and Ma DDF (2019). "Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis." J Neurol Neurosurg Psychiatry 90(5): 514-521. [Open article]
  • Gupta S, Fellows K, Weinstock-Guttman B, Hagemeier J, Zivadinov R and Ramanathan M (2019). "Marijuana Use by Patients with Multiple Sclerosis." Int J MS Care 21(2): 57-62. [Open article]
  • Zivadinov R, Bergsland N, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Lizarraga AA, Kolb C, Hojnacki D and Weinstock-Guttman B (2019). "Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study." J Clin Med 8(3). [Open article]
  • Guan Y, Jakimovski D, Ramanathan M, Weinstock-Guttman B and Zivadinov R (2019). "The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging." Neural Regen Res 14(3): 373-386. [Open article]
  • Zivadinov R, Horakova D, Bergsland N, Hagemeier J, Ramasamy DP, Uher T, Vaneckova M, Havrdova E and Dwyer MG (2019). "A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS." AJNR Am J Neuroradiol 40(3): 446-452. [Open article]
  • Fuchs TA, Benedict RH, Wilding G, Wojcik C, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Zivadinov R and Dwyer MG (2019). "Trait Conscientiousness predicts rate of brain atrophy in multiple sclerosis." Mult Scler: 1352458519858605. [Open article]
  • Jakimovski D, Topolski M, Kimura K, Pandya V, Weinstock-Guttman B and Zivadinov R (2019). "Decrease in Secondary Neck Vessels in Multiple Sclerosis: A 5-year Longitudinal Magnetic Resonance Angiography Study." Curr Neurovasc Res 16(3): 215-223. [Open article]
  • Gandhi S, Marr K, Mancini M, Caprio MG, Jakimovski D, Chandra A, Hagemeier J, Hojnacki D, Kolb C, Weinstock-Guttman B and Zivadinov R (2019). "No association between variations in extracranial venous anatomy and clinical outcomes in multiple sclerosis patients over 5 years." BMC Neurol 19(1): 121. [Open article]
  • Pelizzari L, Lagana MM, Baglio F, Bergsland N, Cecconi P, Viotti S, Pugnetti L, Nemni R, Baselli G, Clerici M and Mendozzi L (2019). "Cerebrovascular reactivity and its correlation with age in patients with multiple sclerosis." Brain Imaging Behav. [Open article]
  • Deshpande HU, Mellis AM, Lisinski JM, Stein JS, Koffarnus MN, Paluch R, Schweser F, Zivadinov R, LaConte SM, Epstein LH and Bickel WK (2019). "Reinforcer pathology: Common neural substrates for delay discounting and snack purchasing in prediabetics." Brain Cogn 132: 80-88. [Open article]
  • Jakimovski D, Guan Y, Ramanathan M, Weinstock-Guttman B and Zivadinov R (2019). "Lifestyle-based modifiable risk factors in multiple sclerosis: review of experimental and clinical findings." Neurodegener Dis Manag 9(3): 149-172. [Open article]
  • Jakimovski D, Topolski M, Kimura K, Marr K, Gandhi S, Ramasamy DP, Bergsland N, Hagemeier J, Weinstock-Guttman B and Zivadinov R (2019). "Abnormal venous postural control: multiple sclerosis-specific change related to gray matter pathology or age-related neurodegenerative phenomena?" Clin Auton Res 29(3): 329-338. [Open article]
  • Vaughn CB, Jakimovski D, Kavak KS, Ramanathan M, Benedict RHB, Zivadinov R and Weinstock-Guttman B (2019). "Epidemiology and treatment of multiple sclerosis in elderly populations." Nat Rev Neurol 15(6): 329-342. [Open article]
  • Browne RW, Jakimovski D, Ziliotto N, Kuhle J, Bernardi F, Weinstock-Guttman B, Zivadinov R and Ramanathan M (2019). "High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus?" J Clin Lipidol 13(4): 654-663 e651. [Open article]
  • Yun JW, Cvek U, Kilgore P, Tsunoda I, Omura S, Sato F, Zivadinov R, Ramanathan M, Minagar A and Alexander JS (2019). "Neurolymphatic biomarkers of brain endothelial inflammatory activation: Implications for multiple sclerosis diagnosis." Life Sci 229: 116-123. [Open article]
  • Bergsland N, Zivadinov R, Schweser F, Hagemeier J, Lichter D and Guttuso T, Jr. (2019). "Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease." Mov Disord 34(7): 1006-1013. [Open article]
  • Fellows Maxwell K, Bhattacharya S, Bodziak ML, Jakimovski D, Hagemeier J, Browne RW, Weinstock-Guttman B, Zivadinov R and Ramanathan M (2019). "Oxysterols and apolipoproteins in multiple sclerosis: a 5 year follow-up study." J Lipid Res 60(7): 1190-1198. [Open article]
  • Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Paunkoski I, Ramasamy DP, Carl E, Hojnacki D, Kolb C, Weinstock-Guttman B and Zivadinov R (2019). "Aging and Brain Atrophy in Multiple Sclerosis." J Neuroimaging 29(4): 527-535. [Open article]
  • Ziliotto N, Zivadinov R, Jakimovski D, Baroni M, Tisato V, Secchiero P, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Bernardi F, Ramanathan M and Marchetti G (2019). "Plasma levels of soluble NCAM in multiple sclerosis." J Neurol Sci 396: 36-41. [Open article]
  • Jakimovski D, Benedict RH, Marr K, Gandhi S, Bergsland N, Weinstock-Guttman B and Zivadinov R (2019). "Lower total cerebral arterial flow contributes to cognitive performance in multiple sclerosis patients." Mult Scler: 1352458518819608. [Open article]
  • Fuchs TA, Wojcik C, Wilding GE, Pol J, Dwyer MG, Weinstock-Guttman B, Zivadinov R and Benedict RH (2019). "Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosis." Mult Scler: 1352458518820272. [Open article]
  • Fuchs TA, Vaughn CB, Benedict RHB, Weinstock-Guttman B, Choudhery S, Carolus K, Rooney P, Ashton K, D PR, Jakimovski D, Zivadinov R and Dwyer MG (2019). "Lower self-report fatigue in multiple sclerosis is associated with localized white matter tract disruption between amygdala, temporal pole, insula, and other connected structures." Mult Scler Relat Disord 27: 298-304. [Open article]
  • Jakimovski D, Gandhi S, Paunkoski I, Bergsland N, Hagemeier J, Ramasamy DP, Hojnacki D, Kolb C, Benedict RHB, Weinstock-Guttman B and Zivadinov R (2019). "Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study." Eur J Neurol 26(1): 87-e88. [Open article]
  • Pol S, Sveinsson M, Sudyn M, Babek N, Siebert D, Bertolino N, Modica CM, Preda M, Schweser F and Zivadinov R (2019). "Teriflunomide's Effect on Glia in Experimental Demyelinating Disease: A Neuroimaging and Histologic Study." J Neuroimaging 29(1): 52-61. [Open article]
  • Ziliotto N, Zivadinov R, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Ramanathan M, Marchetti G and Bernardi F (2019). "Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke?" Thromb Haemost 119(1): 175-178. [Open article]
  • Zivadinov R, Medin J, Khan N, Korn JR, Chitnis T, Naismith RT, Alvarez E, Dwyer MG, Bergsland N, Carl E, Silva D, Weinstock-Guttman B and Group M-MS (2019). "Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study." Mult Scler Relat Disord 27: 65-73. [Open article]
  • Jakimovski D, Ramanathan M, Weinstock-Guttman B, Bergsland N, Ramasamay DP, Carl E, Dwyer MG and Zivadinov R (2019). "Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: A case-controlled magnetization transfer ratio study." Mult Scler: 1352458519828667. [Open article]
  • Taege Y, Hagemeier J, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R and Schweser F (2019). "Assessment of mesoscopic properties of deep gray matter iron through a model-based simultaneous analysis of magnetic susceptibility and R2* - A pilot study in patients with multiple sclerosis and normal controls." Neuroimage 186: 308-320. [Open article]
  • Fuchs TA, Benedict RHB, Bartnik A, Choudhery S, Li X, Mallory M, Oship D, Yasin F, Ashton K, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Zivadinov R and Dwyer MG (2019). "Preserved network functional connectivity underlies cognitive reserve in multiple sclerosis." Hum Brain Mapp 40(18): 5231-5241. [Open article]
  • Zivadinov R, Bergsland N, Hagemeier J, Ramasamy DP, Dwyer MG, Schweser F, Kolb C, Weinstock-Guttman B and Hojnacki D (2019). "Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS." Neurology 93(6): e611-e623. [Open article]
  • Lin F, Zivadinov R, Hagemeier J, Weinstock-Guttman B, Vaughn C, Gandhi S, Jakimovski D, Hulst HE, Benedict RH, Bergsland N, Fuchs T and Dwyer MG (2019). "Altered nuclei-specific thalamic functional connectivity patterns in multiple sclerosis and their associations with fatigue and cognition." Mult Scler 25(9): 1243-1254. [Open article]
  • Zivadinov R and Dwyer MG (2019). "Network Dynamics and Cognitive Impairment in Multiple Sclerosis: Functional MRI-based Decoupling of Complex Relationships." Radiology 292(2): 458-459. [Open article]
  • Bergsland N, Ramasamy D, Tavazzi E, Hojnacki D, Weinstock-Guttman B and Zivadinov R (2019). "Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study." AJNR Am J Neuroradiol 40(4): 620-625. [Open article]
  • Jakimovski D, Weinstock-Guttman B, Gandhi S, Guan Y, Hagemeier J, Ramasamy DP, Fuchs TA, Browne RW, Bergsland N, Dwyer MG, Ramanathan M and Zivadinov R (2019). "Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study." J Neurol 266(4): 866-875. [Open article]
  • Pol S, Schweser F, Bertolino N, Preda M, Sveinsson M, Sudyn M, Babek N and Zivadinov R (2019). "Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis." Exp Neurol 314: 82-90. [Open article]
  • Uher T, Vaneckova M, Krasensky J, Sobisek L, Tyblova M, Volna J, Seidl Z, Bergsland N, Dwyer MG, Zivadinov R, De Stefano N, Sormani MP, Havrdova EK and Horakova D (2019). "Pathological cut-offs of global and regional brain volume loss in multiple sclerosis." Mult Scler 25(4): 541-553. [Open article]
  • Zivadinov R, Kresa-Reahl K, Weinstock-Guttman B, Edwards K, Burudpakdee C, Bergsland N, Dwyer MG, Khatri B, Thangavelu K, Chavin J, Mandel M and Cohan S (2019). "Comparative effectiveness of teriflunomide and dimethyl fumarate in patients with relapsing forms of MS in the retrospective real-world Teri-RADAR study." J Comp Eff Res 8(5): 305-316. [Open article]
  • Jakimovski D, Weinstock-Guttman B, Roy S, Jaworski M, 3rd, Hancock L, Nizinski A, Srinivasan P, Fuchs TA, Szigeti K, Zivadinov R and Benedict RHB (2019). "Cognitive Profiles of Aging in Multiple Sclerosis." Front Aging Neurosci 11: 105. [Open article]
  • Ozel O, Vaughn CB, Eckert SP, Jakimovski D, Lizarraga AA and Weinstock-Guttman B (2019). "Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives." Patient Relat Outcome Meas 10: 373-384. [Open article]
  • Pelizzari L, Lagana MM, Di Tella S, Rossetto F, Bergsland N, Nemni R, Clerici M and Baglio F (2019). "Combined Assessment of Diffusion Parameters and Cerebral Blood Flow Within Basal Ganglia in Early Parkinson's Disease." Front Aging Neurosci 11: 134. [Open article]
  • Pelizzari L, Lagana MM, Rossetto F, Bergsland N, Galli M, Baselli G, Clerici M, Nemni R and Baglio F (2019). "Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson's disease." Ther Adv Neurol Disord 12: 1756286419838354. [Open article]
  • Shi R, Jung JH and Schweser F (2019). "Two-dimensional local Fourier image reconstruction via domain decomposition Fourier continuation method." PLoS One 14(1): e0197963. [Open article]
  • Ziliotto N, Bernardi F, Jakimovski D and Zivadinov R (2019). "Coagulation Pathways in Neurological Diseases: Multiple Sclerosis." Front Neurol 10: 409. [Open article]

2018

  • Baker JG, Leddy JJ, Hinds AL, Haider MN, Shucard J, Sharma T, Hernandez S, Durinka J, Zivadinov R and Willer BS (2018). "An Exploratory Study of Mild Cognitive Impairment of Retired Professional Contact Sport Athletes." J Head Trauma Rehabil 33(5): E16-E23. [Open article]
  • Willer BS, Zivadinov R, Haider MN, Miecznikowski JC and Leddy JJ (2018). "A Preliminary Study of Early-Onset Dementia of Former Professional Football and Hockey Players." J Head Trauma Rehabil 33(5): E1-E8. [Open article]
  • Zivadinov R, Polak P, Schweser F, Bergsland N, Hagemeier J, Dwyer MG, Ramasamy DP, Baker JG, Leddy JJ and Willer BS (2018). "Multimodal Imaging of Retired Professional Contact Sport Athletes Does Not Provide Evidence of Structural and Functional Brain Damage." J Head Trauma Rehabil 33(5): E24-E32. [Open article]
  • Dwyer MG, Bergsland N, Ramasamy DP, Jakimovski D, Weinstock-Guttman B and Zivadinov R (2018). "Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis." J Neuroimaging 28(5): 490-495. [Open article]
  • Fuchs TA, Dwyer MG, Kuceyeski A, Choudhery S, Carolus K, Li X, Mallory M, Weinstock-Guttman B, Jakimovski D, Ramasamy D, Zivadinov R and Benedict RHB (2018). "White matter tract network disruption explains reduced conscientiousness in multiple sclerosis." Hum Brain Mapp 39(9): 3682-3690. [Open article]
  • Pelizzari L, Jakimovski D, Lagana MM, Bergsland N, Hagemeier J, Baselli G, Weinstock-Guttman B and Zivadinov R (2018). "Five-Year Longitudinal Study of Neck Vessel Cross-Sectional Area in Multiple Sclerosis." AJNR Am J Neuroradiol 39(9): 1703-1709. [Open article]
  • Ziliotto N, Bernardi F, Jakimovski D, Baroni M, Marchetti G, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Schweser F, Zamboni P, Ramanathan M and Zivadinov R (2018). "Hemostasis biomarkers in multiple sclerosis." Eur J Neurol 25(9): 1169-1176. [Open article]
  • Jakimovski D, Weinstock-Guttman B, Hagemeier J, Vaughn CB, Kavak KS, Gandhi S, Bennett SE, Fuchs TA, Bergsland N, Dwyer MG, Benedict RHB and Zivadinov R (2018). "Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage." J Neurol Sci 393: 128-134. [Open article]
  • Bergsland N, Schweser F, Dwyer MG, Weinstock-Guttman B, Benedict RHB and Zivadinov R (2018). "Thalamic white matter in multiple sclerosis: A combined diffusion-tensor imaging and quantitative susceptibility mapping study." Hum Brain Mapp 39(10): 4007-4017. [Open article]
  • Ziliotto N, Bernardi F, Jakimovski D, Baroni M, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Zamboni P, Marchetti G, Zivadinov R and Ramanathan M (2018). "Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients." Mult Scler Relat Disord 25: 37-42. [Open article]
  • Jakimovski D, Kolb C, Ramanathan M, Zivadinov R and Weinstock-Guttman B (2018). "Interferon beta for Multiple Sclerosis." Cold Spring Harb Perspect Med 8(11). [Open article]
  • Zamboni P and Zivadinov R (2018). "Extracranial Veins in Multiple Sclerosis: Is There a Role for Vascular Surgery?" Eur J Vasc Endovasc Surg 56(5): 618-621. [Open article]
  • Zivadinov R, Bergsland N and Dwyer MG (2018). "Atrophied brain lesion volume, a magnetic resonance imaging biomarker for monitoring neurodegenerative changes in multiple sclerosis." Quant Imaging Med Surg 8(10): 979-983. [Open article]
  • Zivadinov R, Tavazzi E, Bergsland N, Hagemeier J, Lin F, Dwyer MG, Carl E, Kolb C, Hojnacki D, Ramasamy D, Durfee J, Weinstock-Guttman B and Schweser F (2018). "Brain Iron at Quantitative MRI Is Associated with Disability in Multiple Sclerosis." Radiology 289(2): 487-496. [Open article]
  • Zivadinov R, Bergsland N, Hagemeier J, Carl E, Kolb H, Hojnacki D and Weinstock-Guttman B (2018). "Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures." J Neurol Sci 388: 175-181. [Open article]
  • Lansky AJ, Messe SR, Brickman AM, Dwyer M, Bart van der Worp H, Lazar RM, Pietras CG, Abrams KJ, McFadden E, Petersen NH, Browndyke J, Prendergast B, Ng VG, Cutlip DE, Kapadia S, Krucoff MW, Linke A, Scala Moy C, Schofer J, van Es GA, Virmani R, Popma J, Parides MK, Kodali S, Bilello M, Zivadinov R, Akar J, Furie KL, Gress D, Voros S, Moses J, Greer D, Forrest JK, Holmes D, Kappetein AP, Mack M and Baumbach A (2018). "Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative." Eur Heart J 39(19): 1687-1697. [Open article]
  • Roy S, Drake A, Snyder S, Cline B, Khan A, Fuchs T, Zivadinov R, Weinstock-Guttman B, Szigeti K and Benedict RHB (2018). "Preliminary investigation of cognitive function in aged multiple sclerosis patients: Challenges in detecting comorbid Alzheimer's disease." Mult Scler Relat Disord 22: 52-56. [Open article]
  • Uher T, Krasensky J, Sobisek L, Seidl Z, Bergsland N, Dwyer MG, Kubala Havrdova E, Zivadinov R, Horakova D and Vaneckova M (2018). "The Role of High-Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis." J Neuroimaging 28(3): 328-337. [Open article]
  • Guttuso T, Jr., Bergsland N, Hagemeier J, Lichter DG, Pasternak O and Zivadinov R (2018). "Substantia Nigra Free Water Increases Longitudinally in Parkinson Disease." AJNR Am J Neuroradiol 39(3): 479-484. [Open article]
  • Langkammer C, Schweser F, Shmueli K, Kames C, Li X, Guo L, Milovic C, Kim J, Wei H, Bredies K, Buch S, Guo Y, Liu Z, Meineke J, Rauscher A, Marques JP and Bilgic B (2018). "Quantitative susceptibility mapping: Report from the 2016 reconstruction challenge." Magn Reson Med 79(3): 1661-1673. [Open article]
  • Zivadinov R, Hagemeier J, Bergsland N, Tavazzi E and Weinstock-Guttman B (2018). "Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study." Eur J Neurol 25(3): 584-e536. [Open article]
  • Zivadinov R and Weinstock-Guttman B (2018). "Multiple sclerosis: Extracranial venous angioplasty is ineffective to treat MS." Nat Rev Neurol 14(3): 129-130. [Open article]
  • Kim S, Chang L, Weinstock-Guttman B, Gandhi S, Jakimovski D, Carl E, Zivadinov R and Ramanathan M (2018). "Complementary and Alternative Medicine Usage by Multiple Sclerosis Patients: Results from a Prospective Clinical Study." J Altern Complement Med 24(6): 596-602. [Open article]
  • Dwyer MG, Lazar RM and Zivadinov R (2018). "Reply: Don't Leave the Back Door Open." JACC Cardiovasc Interv 11(14): 1420. [Open article]
  • Zivadinov R, Medin J, Khan N, Korn JR, Bergsland N, Dwyer MG, Chitnis T, Naismith RT, Alvarez E, Kinkel P, Cohan S, Hunter SF, Silva D, Weinstock-Guttman B and investigators M-M (2018). "Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS." J Neuroimaging 28(4): 399-405. [Open article]
  • Roy S, Drake A, Fuchs T, Dwyer MG, Zivadinov R, Chapman BP, Weinstock-Guttman B and Benedict RH (2018). "Longitudinal personality change associated with cognitive decline in multiple sclerosis." Mult Scler: 1352458517753720. [Open article]
  • Belov P, Jakimovski D, Krawiecki J, Magnano C, Hagemeier J, Pelizzari L, Weinstock-Guttman B and Zivadinov R (2018). "Lower Arterial Cross-Sectional Area of Carotid and Vertebral Arteries and Higher Frequency of Secondary Neck Vessels Are Associated with Multiple Sclerosis." AJNR Am J Neuroradiol 39(1): 123-130. [Open article]
  • Pelizzari L, Lagana MM, Jakimovski D, Bergsland N, Hagemeier J, Baselli G and Zivadinov R (2018). "Neck Vessel Cross-Sectional Area Measured with MRI: Scan-Rescan Reproducibility for Longitudinal Evaluations." J Neuroimaging 28(1): 48-56. [Open article]
  • Weinstock-Guttman B, Medin J, Khan N, Korn JR, Lathi E, Silversteen J, Calkwood J, Silva D, Zivadinov R and Group M-MS (2018). "Assessing 'No Evidence of Disease Activity' Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study." CNS Drugs 32(1): 75-84. [Open article]
  • Lazar RM, Pavol MA, Bormann T, Dwyer MG, Kraemer C, White R, Zivadinov R, Wertheimer JC, Thone-Otto A, Ravdin LD, Naugle R, Mechanic-Hamilton D, Garmoe WS, Stringer AY, Bender HA, Kapadia SR, Kodali S, Ghanem A, Linke A, Mehran R, Virmani R, Nazif T, Parhizgar A and Leon MB (2018). "Neurocognition and Cerebral Lesion Burden in High-Risk Patients Before Undergoing Transcatheter Aortic Valve Replacement: Insights From the SENTINEL Trial." JACC Cardiovasc Interv 11(4): 384-392. [Open article]
  • Schweser F, Raffaini Duarte Martins AL, Hagemeier J, Lin F, Hanspach J, Weinstock-Guttman B, Hametner S, Bergsland N, Dwyer MG and Zivadinov R (2018). "Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality." Neuroimage 167: 438-452. [Open article]
  • Roy S, Drake AS, Eizaguirre MB, Zivadinov R, Weinstock-Guttman B, Chapman BP and Benedict RH (2018). "Trait neuroticism, extraversion, and conscientiousness in multiple sclerosis: Link to cognitive impairment?" Mult Scler 24(2): 205-213. [Open article]
  • Zivadinov R, Bergsland N, Korn JR, Dwyer MG, Khan N, Medin J, Price JC, Weinstock-Guttman B, Silva D and Group M-MS (2018). "Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS." AJNR Am J Neuroradiol 39(2): 289-295. [Open article]
  • Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Paunkoski I, Ramasamy DP, Silva D, Carl E, Hojnacki D, Kolb C, Weinstock-Guttman B and Zivadinov R (2018). "Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine." AJNR Am J Neuroradiol 39(12): 2237-2242. [Open article]
  • Schweser F and Zivadinov R (2018). "Quantitative susceptibility mapping (QSM) with an extended physical model for MRI frequency contrast in the brain: a proof-of-concept of quantitative susceptibility and residual (QUASAR) mapping." NMR Biomed 31(12): e3999. [Open article]
  • Fuchs TA, Carolus K, Benedict RHB, Bergsland N, Ramasamy D, Jakimovski D, Weinstock-Guttman B, Kuceyeski A, Zivadinov R and Dwyer MG (2018). "Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study." AJNR Am J Neuroradiol 39(8): 1480-1486. [Open article]
  • Marr K, Jakimovski D, Mancini M, Carl E and Zivadinov R (2018). "Jugular Venous Flow Quantification Using Doppler Sonography." Ultrasound Med Biol 44(8): 1762-1769. [Open article]
  • Zivadinov R (2018). "Why Is Cognitive Impairment Present in Multiple Sclerosis? Insights from Functional MRI." Radiology 288(2): 552-553. [Open article]
  • Zivadinov R, Khan N, Korn JR, Lathi E, Silversteen J, Calkwood J, Kolodny S, Silva D, Medin J, Weinstock-Guttman B and group M-Ms (2018). "No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study." Curr Med Res Opin 34(8): 1431-1440. [Open article]
  • Zivadinov R, Tavazzi E, Hagemeier J, Carl E, Hojnacki D, Kolb C and Weinstock-Guttman B (2018). "The Effect of Glatiramer Acetate on Retinal Nerve Fiber Layer Thickness in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study." CNS Drugs 32(8): 763-770. [Open article]
  • Zivadinov R, Bergsland N, Hagemeier J, Tavazzi E, Ramasamy DP, Durfee J, Cherneva M, Carl E, Carl J, Kolb C, Hojnacki D and Weinstock-Guttman B (2018). "Effect of switching from glatiramer acetate 20mg/daily to glatiramer acetate 40mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study." J Neurol Sci 387: 152-156. [Open article]
  • Zivadinov R, Ramasamy DP, Hagemeier J, Kolb C, Bergsland N, Schweser F, Dwyer MG, Weinstock-Guttman B and Hojnacki D (2018). "Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis." AJNR Am J Neuroradiol 39(4): 642-647. [Open article]
  • Bergsland N, Horakova D, Dwyer MG, Uher T, Vaneckova M, Tyblova M, Seidl Z, Krasensky J, Havrdova E and Zivadinov R (2018). "Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study." Neuroimage Clin 17: 444-451. [Open article]
  • Dwyer MG, Hagemeier J, Bergsland N, Horakova D, Korn JR, Khan N, Uher T, Medin J, Silva D, Vaneckova M, Havrdova EK and Zivadinov R (2018). "Establishing pathological cut-offs for lateral ventricular volume expansion rates." Neuroimage Clin 18: 494-501. [Open article]
  • Hagemeier J, Ramanathan M, Schweser F, Dwyer MG, Lin F, Bergsland N, Weinstock-Guttman B and Zivadinov R (2018). "Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals." Neuroimage Clin 17: 530-540. [Open article]
  • Hagemeier J, Zivadinov R, Dwyer MG, Polak P, Bergsland N, Weinstock-Guttman B, Zalis J, Deistung A, Reichenbach JR and Schweser F (2018). "Changes of deep gray matter magnetic susceptibility over 2 years in multiple sclerosis and healthy control brain." Neuroimage Clin 18: 1007-1016. [Open article]
  • Schweser F, Preda M and Zivadinov R (2018). "Susceptibility Weighted MRI in Rodents at 9.4 T." Methods Mol Biol 1718: 205-234. [Open article]
  • Tutino VM, Rajabzadeh-Oghaz H, Chandra AR, Gutierrez LC, Schweser F, Preda M, Chien A, Vakharia K, Ionita C, Siddiqui A and Kolega J (2018). "9.4T Magnetic Resonance Imaging of the Mouse Circle of Willis Enables Serial Characterization of Flow-Induced Vascular Remodeling by Computational Fluid Dynamics." Curr Neurovasc Res 15(4): 312-325. [Open article]

2017

  • Jakimovski D, Weinstock-Guttman B, Ramanathan M, Kolb C, Hojnacki D, Minagar A and Zivadinov R (2017). "Ocrelizumab: a B-cell depleting therapy for multiple sclerosis." Expert Opin Biol Ther 17(9): 1163-1172. [Open article]
  • Roy S, Frndak S, Drake AS, Irwin L, Zivadinov R, Weinstock-Guttman B and Benedict RH (2017). "Differential effects of aging on motor and cognitive functioning in multiple sclerosis." Mult Scler 23(10): 1385-1393. [Open article]
  • Zivadinov R, Ramasamy DP, Vaneckova M, Gandhi S, Chandra A, Hagemeier J, Bergsland N, Polak P, Benedict RH, Hojnacki D and Weinstock-Guttman B (2017). "Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study." Mult Scler 23(10): 1336-1345. [Open article]
  • Younus Z, Vaughn CB, Sanai SA, Kavak KS, Gupta S, Nadeem M, Teter BE, Noyes K, Zivadinov R, Edwards K, Coyle PK, Goodman A, Weinstock-Guttman B and New York State Multiple Sclerosis C (2017). "Fatigue and Mood States in Nursing Home and Nonambulatory Home-Based Patients with Multiple Sclerosis." Int J MS Care 19(6): 297-302. [Open article]
  • Hanspach J, Dwyer MG, Bergsland NP, Feng X, Hagemeier J, Bertolino N, Polak P, Reichenbach JR, Zivadinov R and Schweser F (2017). "Methods for the computation of templates from quantitative magnetic susceptibility maps (QSM): Toward improved atlas- and voxel-based analyses (VBA)." J Magn Reson Imaging 46(5): 1474-1484. [Open article]
  • Uher T, Krasensky J, Vaneckova M, Sobisek L, Seidl Z, Havrdova E, Bergsland N, Dwyer MG, Horakova D and Zivadinov R (2017). "A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study." J Neuroimaging 27(6): 620-629. [Open article]
  • Khan O, Rieckmann P, Boyko A, Selmaj K, Ashtamker N, Davis MD, Kolodny S and Zivadinov R (2017). "Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study." Mult Scler 23(6): 818-829. [Open article]
  • Mukhopadhyay S, Fellows K, Browne RW, Khare P, Krishnan Radhakrishnan S, Hagemeier J, Weinstock-Guttman B, Zivadinov R and Ramanathan M (2017). "Interdependence of oxysterols with cholesterol profiles in multiple sclerosis." Mult Scler 23(6): 792-801. [Open article]
  • Zivadinov R, Khan N, Medin J, Christoffersen P, Price J, Korn JR, Bonzani I, Dwyer MG, Bergsland N, Carl E, Silva D and Weinstock-Guttman B (2017). "An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study." J Neuroimaging 27(3): 339-347. [Open article]
  • Belov P, Magnano C, Krawiecki J, Hagemeier J, Bergsland N, Beggs C and Zivadinov R (2017). "Age-related brain atrophy may be mitigated by internal jugular vein enlargement in male individuals without neurologic disease." Phlebology 32(2): 125-134. [Open article]
  • Feng X, Deistung A, Dwyer MG, Hagemeier J, Polak P, Lebenberg J, Frouin F, Zivadinov R, Reichenbach JR and Schweser F (2017). "An improved FSL-FIRST pipeline for subcortical gray matter segmentation to study abnormal brain anatomy using quantitative susceptibility mapping (QSM)." Magn Reson Imaging 39: 110-122. [Open article]
  • Caprio MG, Marr K, Gandhi S, Jakimovski D, Hagemeier J, Weinstock-Guttman B, Zivadinov R and Mancini M (2017). "Centralized and Local Color Doppler Ultrasound Reading Agreement for Diagnosis of the Chronic Cerebrospinal Venous Insufficiency in Patients with Multiple Sclerosis." Curr Neurovasc Res 14(3): 266-273. [Open article]
  • Kapadia SR, Kodali S, Makkar R, Mehran R, Lazar RM, Zivadinov R, Dwyer MG, Jilaihawi H, Virmani R, Anwaruddin S, Thourani VH, Nazif T, Mangner N, Woitek F, Krishnaswamy A, Mick S, Chakravarty T, Nakamura M, McCabe JM, Satler L, Zajarias A, Szeto WY, Svensson L, Alu MC, White RM, Kraemer C, Parhizgar A, Leon MB, Linke A and Investigators ST (2017). "Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement." J Am Coll Cardiol 69(4): 367-377. [Open article]
  • Bergsland N, Tavazzi E, Lagana MM, Baglio F, Cecconi P, Viotti S, Zivadinov R, Baselli G and Rovaris M (2017). "White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis." J Neuroimaging 27(1): 107-113. [Open article]
  • Uher T, Vaneckova M, Sobisek L, Tyblova M, Seidl Z, Krasensky J, Ramasamy D, Zivadinov R, Havrdova E, Kalincik T and Horakova D (2017). "Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis." Mult Scler 23(1): 51-61. [Open article]
  • Lansky AJ, Messe SR, Brickman AM, Dwyer M, van der Worp HB, Lazar RM, Pietras CG, Abrams KJ, McFadden E, Petersen NH, Browndyke J, Prendergast B, Ng VG, Cutlip DE, Kapadia S, Krucoff MW, Linke A, Moy CS, Schofer J, van Es GA, Virmani R, Popma J, Parides MK, Kodali S, Bilello M, Zivadinov R, Akar J, Furie KL, Gress D, Voros S, Moses J, Greer D, Forrest JK, Holmes D, Kappetein AP, Mack M and Baumbach A (2017). "Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative." J Am Coll Cardiol 69(6): 679-691. [Open article]
  • Uher T, Fellows K, Horakova D, Zivadinov R, Vaneckova M, Sobisek L, Tyblova M, Seidl Z, Krasensky J, Bergsland N, Weinstock-Guttman B, Havrdova E and Ramanathan M (2017). "Serum lipid profile changes predict neurodegeneration in interferon-beta1a-treated multiple sclerosis patients." J Lipid Res 58(2): 403-411. [Open article]
  • Uher T, Havrdova E, Sobisek L, Krasensky J, Vaneckova M, Seidl Z, Tyblova M, Ramasamy D, Zivadinov R and Horakova D (2017). "Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?" Mult Scler 23(2): 242-252. [Open article]
  • Woodward MR, Dwyer MG, Bergsland N, Hagemeier J, Zivadinov R, Benedict RH and Szigeti K (2017). "Olfactory identification deficit predicts white matter tract impairment in Alzheimer's disease." Psychiatry Res Neuroimaging 266: 90-95. [Open article]
  • Deistung A, Schweser F and Reichenbach JR (2017). "Overview of quantitative susceptibility mapping." NMR Biomed 30(4). [Open article]
  • Mokin M, Zivadinov R, Dwyer MG, Lazar RM, Hopkins LN and Siddiqui AH (2017). "Transcatheter aortic valve replacement: perioperative stroke and beyond." Expert Rev Neurother 17(4): 327-334. [Open article]
  • Ozbay PS, Deistung A, Feng X, Nanz D, Reichenbach JR and Schweser F (2017). "A comprehensive numerical analysis of background phase correction with V-SHARP." NMR Biomed 30(4). [Open article]
  • Robinson SD, Bredies K, Khabipova D, Dymerska B, Marques JP and Schweser F (2017). "An illustrated comparison of processing methods for MR phase imaging and QSM: combining array coil signals and phase unwrapping." NMR Biomed 30(4). [Open article]
  • Schweser F, Robinson SD, de Rochefort L, Li W and Bredies K (2017). "An illustrated comparison of processing methods for phase MRI and QSM: removal of background field contributions from sources outside the region of interest." NMR Biomed 30(4). [Open article]
  • Dwyer MG, Silva D, Bergsland N, Horakova D, Ramasamy D, Durfee J, Vaneckova M, Havrdova E and Zivadinov R (2017). "Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis." Neuroimage Clin 15: 769-779. [Open article]
  • Modica CM, Schweser F, Sudyn ML, Bertolino N, Preda M, Polak P, Siebert DM, Krawiecki JC, Sveinsson M, Hagemeier J, Dwyer MG, Pol S and Zivadinov R (2017). "Effect of teriflunomide on cortex-basal ganglia-thalamus (CxBGTh) circuit glutamatergic dysregulation in the Theiler's Murine Encephalomyelitis Virus mouse model of multiple sclerosis." PLoS One 12(8): e0182729. [Open article]

2016

  • Bergsland N, Zivadinov R, Dwyer MG, Weinstock-Guttman B and Benedict RH (2016). "Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients." Mult Scler 22(10): 1327-1336. [Open article]
  • Klohs J, Deistung A, Ielacqua GD, Seuwen A, Kindler D, Schweser F, Vaas M, Kipar A, Reichenbach JR and Rudin M (2016). "Quantitative assessment of microvasculopathy in arcAbeta mice with USPIO-enhanced gradient echo MRI." J Cereb Blood Flow Metab 36(9): 1614-1624. [Open article]
  • Weinstock-Guttman B, Hagemeier J, Kavak KS, Saini V, Patrick K, Ramasamy DP, Nadeem M, Carl E, Hojnacki D and Zivadinov R (2016). "Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation." J Neurol Neurosurg Psychiatry 87(9): 937-943. [Open article]
  • Zivadinov R, Dwyer MG and Bergsland N (2016). "Brain atrophy measurements should be used to guide therapy monitoring in MS - YES." Mult Scler 22(12): 1522-1524. [Open article]
  • Zivadinov R, Uher T, Hagemeier J, Vaneckova M, Ramasamy DP, Tyblova M, Bergsland N, Seidl Z, Dwyer MG, Krasensky J, Havrdova E and Horakova D (2016). "A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients." Mult Scler 22(13): 1709-1718. [Open article]
  • Zivadinov R, Jakimovski D, Gandhi S, Ahmed R, Dwyer MG, Horakova D, Weinstock-Guttman B, Benedict RR, Vaneckova M, Barnett M and Bergsland N (2016). "Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine." Expert Rev Neurother: 1-17. [Open article]
  • Gupta S, Zivadinov R, Ramanathan M and Weinstock-Guttman B (2016). "Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?" Expert Rev Neurother: 1-11. [Open article]
  • Roy S, Schwartz CE, Duberstein P, Dwyer MG, Zivadinov R, Bergsland N, Powell V, Weinstock-Guttman B and Benedict RH (2016). "Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis." J Int Neuropsychol Soc: 1-8. [Open article]
  • Sanai SA, Saini V, Benedict RH, Zivadinov R, Teter BE, Ramanathan M and Weinstock-Guttman B (2016). "Aging and multiple sclerosis." Mult Scler 22(6): 717-725. [Open article]
  • Uher T, Horakova D, Tyblova M, Zeman D, Krasulova E, Mrazova K, Seidl Z, Vaneckova M, Krasensky J, Weinstock-Guttman B, Ramanathan M, Havrdova E and Zivadinov R (2016). "Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later." Mult Scler 22(6): 770-781. [Open article]
  • Greenberg SJ, Zivadinov R, Lee-Kwen P, Sharma J, Planter M, Umhauer M, Glenister N and Bakshi R (2016). "Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease." Ther Adv Neurol Disord 9(2): 105-117. [Open article]
  • Schweser F, Deistung A and Reichenbach JR (2016). "Foundations of MRI phase imaging and processing for Quantitative Susceptibility Mapping (QSM)." Z Med Phys 26(1): 6-34. [Open article]
  • Zivadinov R, Hojnacki D, Bergsland N, Kennedy C, Hagemeier J, Melia R, Ramasamy DP, Durfee J, Carl E, Dwyer MG and Weinstock-Guttman B (2016). "Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years." Eur J Neurol 23(6): 1101-1109. [Open article]
  • Zivadinov R, Raj B, Ramanathan M, Teter B, Durfee J, Dwyer MG, Bergsland N, Kolb C, Hojnacki D, Benedict RH and Weinstock-Guttman B (2016). "Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis." AJNR Am J Neuroradiol 37(6): 1010-1016. [Open article]
  • Gandhi S, Jakimovski D, Ahmed R, Hojnacki D, Kolb C, Weinstock-Guttman B and Zivadinov R (2016). "Use of natalizumab in multiple sclerosis: current perspectives." Expert Opin Biol Ther: 1-12. [Open article]
  • Beggs CB, Magnano C, Shepherd SJ, Belov P, Ramasamy DP, Hagemeier J and Zivadinov R (2016). "Dirty-Appearing White Matter in the Brain is Associated with Altered Cerebrospinal Fluid Pulsatility and Hypertension in Individuals without Neurologic Disease." J Neuroimaging 26(1): 136-143. [Open article]
  • Modica CM, Bergsland N, Dwyer MG, Ramasamy DP, Carl E, Zivadinov R and Benedict RH (2016). "Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis." Mult Scler 22(1): 36-42. [Open article]
  • Kappus N, Weinstock-Guttman B, Hagemeier J, Kennedy C, Melia R, Carl E, Ramasamy DP, Cherneva M, Durfee J, Bergsland N, Dwyer MG, Kolb C, Hojnacki D, Ramanathan M and Zivadinov R (2016). "Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis." J Neurol Neurosurg Psychiatry 87(2): 181-187. [Open article]
  • Motl RW, Zivadinov R, Bergsland N and Benedict RH (2016). "Thalamus volume and ambulation in multiple sclerosis: a cross-sectional study." Neurodegener Dis Manag 6(1): 23-29. [Open article]
  • Zivadinov R, Cerza N, Hagemeier J, Carl E, Badgett D, Ramasamy DP, Weinstock-Guttman B and Ramanathan M (2016). "Humoral response to EBV is associated with cortical atrophy and lesion burden in patients with MS." Neurol Neuroimmunol Neuroinflamm 3(1): e190. [Open article]
  • Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, Klawiter EC, Mainero C, Massacesi L, McFarland H, Nelson F, Ontaneda D, Rauscher A, Rooney WD, Samaraweera AP, Shinohara RT, Sobel RA, Solomon AJ, Treaba CA, Wuerfel J, Zivadinov R, Sicotte NL, Pelletier D, Reich DS and Cooperative N (2016). "The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative." Nat Rev Neurol 12(12): 714-722. [Open article]
  • Zivadinov R, Ramasamy DP, Benedict RR, Polak P, Hagemeier J, Magnano C, Dwyer MG, Bergsland N, Bertolino N, Weinstock-Guttman B, Kolb C, Hojnacki D, Utriainen D, Haacke EM and Schweser F (2016). "Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study." Radiology 281(3): 884-895. [Open article]
  • Banwell B, Arnold DL, Tillema JM, Rocca MA, Filippi M, Weinstock-Guttman B, Zivadinov R and Sormani MP (2016). "MRI in the evaluation of pediatric multiple sclerosis." Neurology 87(9 Suppl 2): S88-96. [Open article]
  • Hagemeier J, Woodward MR, Rafique UA, Amrutkar CV, Bergsland N, Dwyer MG, Benedict R, Zivadinov R and Szigeti K (2016). "Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy." Psychiatry Res 255: 87-93. [Open article]
  • Haussig S, Mangner N, Dwyer MG, Lehmkuhl L, Lucke C, Woitek F, Holzhey DM, Mohr FW, Gutberlet M, Zivadinov R, Schuler G and Linke A (2016). "Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial." JAMA 316(6): 592-601. [Open article]
  • Beatty C, Bowler RA, Farooq O, Dudeck L, Ramasamy D, Yeh EA, Zivadinov R, Weinstock-Guttman B and Parrish JB (2016). "Long-Term Neurocognitive, Psychosocial, and Magnetic Resonance Imaging Outcomes in Pediatric-Onset Acute Disseminated Encephalomyelitis." Pediatr Neurol 57: 64-73. [Open article]
  • Roy S, Rodgers J, Drake AS, Zivadinov R, Weinstock-Guttman B and Benedict RH (2016). "Stable neuropsychiatric status in multiple sclerosis: a 3-year study." Mult Scler 22(4): 569-574. [Open article]
  • Beggs CB, Magnano C, Belov P, Krawiecki J, Ramasamy DP, Hagemeier J and Zivadinov R (2016). "Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients." PLoS One 11(5): e0153960. [Open article]
  • Doring TM, Granado V, Rueda F, Deistung A, Reichenbach JR, Tukamoto G, Gasparetto EL and Schweser F (2016). "Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study." PLoS One 11(5): e0155027. [Open article]
  • Magnano C, Belov P, Krawiecki J, Hagemeier J, Beggs C and Zivadinov R (2016). "Internal Jugular Vein Cross-Sectional Area Enlargement Is Associated with Aging in Healthy Individuals." PLoS One 11(2): e0149532. [Open article]
  • Schwartz CE, Dwyer MG, Benedict R, Weinstock-Guttman B, Bergsland NP, Li J, Ramanathan M and Zivadinov R (2016). "Reserve-related activities and MRI metrics in multiple sclerosis patients and healthy controls: an observational study." BMC Neurol 16: 108. [Open article]
  • Zivadinov R, Cookfair DL, Krupp L, Miller AE, Lava N, Coyle PK, Goodman AD, Jubelt B, Lenihan M, Herbert J, Gottesman M, Snyder DH, Apatoff BR, Teter BE, Perel AB, Munschauer F and Weinstock-Guttman B (2016). "Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC)." BMC Neurol 16(1): 102. [Open article]

2015

  • Mak E, Dwyer MG, Ramasamy DP, Au WL, Tan LC, Zivadinov R and Kandiah N (2015). "White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease." J Neuroimaging 25(5): 754-760. [Open article]
  • Cesar B, Dwyer MG, Shucard JL, Polak P, Bergsland N, Benedict RH, Weinstock-Guttman B, Shucard DW and Zivadinov R (2015). "Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus." AJNR Am J Neuroradiol 36(10): 1874-1883. [Open article]
  • Fellows K, Uher T, Browne RW, Weinstock-Guttman B, Horakova D, Posova H, Vaneckova M, Seidl Z, Krasensky J, Tyblova M, Havrdova E, Zivadinov R and Ramanathan M (2015). "Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients." J Lipid Res 56(10): 2010-2018. [Open article]
  • Reichenbach JR, Schweser F, Serres B and Deistung A (2015). "Quantitative Susceptibility Mapping: Concepts and Applications." Clin Neuroradiol 25 Suppl 2: 225-230. [Open article]
  • Zivadinov R, Dwyer MG, Ramasamy DP, Davis MD, Steinerman JR and Khan O (2015). "The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis." J Neuroimaging 25(6): 989-995. [Open article]
  • Polak P, Leddy JJ, Dwyer MG, Willer B and Zivadinov R (2015). "Diffusion tensor imaging alterations in patients with postconcussion syndrome undergoing exercise treatment: a pilot longitudinal study." J Head Trauma Rehabil 30(2): E32-42. [Open article]
  • Zivadinov R, Dwyer M, Barkay H, Steinerman JR, Knappertz V and Khan O (2015). "Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense "black holes": a post hoc magnetic resonance imaging analysis." J Neurol 262(3): 648-653. [Open article]
  • Zivadinov R, Dwyer M, Markovic-Plese S, Hayward B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Dangond F and Weinstock-Guttman B (2015). "A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis." Ther Adv Neurol Disord 8(2): 59-70. [Open article]
  • Kavak KS, Teter BE, Hagemeier J, Zakalik K, Weinstock-Guttman B and New York State Multiple Sclerosis C (2015). "Higher weight in adolescence and young adulthood is associated with an earlier age at multiple sclerosis onset." Mult Scler 21(7): 858-865. [Open article]
  • Uher T, Horakova D, Kalincik T, Bergsland N, Tyblova M, Ramasamy DP, Seidl Z, Vaneckova M, Krasensky J, Havrdova E and Zivadinov R (2015). "Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon beta-1a." Eur J Neurol 22(7): 1113-1123. [Open article]
  • Modica CM, Zivadinov R, Dwyer MG, Bergsland N, Weeks AR and Benedict RH (2015). "Iron and volume in the deep gray matter: association with cognitive impairment in multiple sclerosis." AJNR Am J Neuroradiol 36(1): 57-62. [Open article]
  • Jiang J, Kokeny P, Ying W, Magnano C, Zivadinov R and Mark Haacke E (2015). "Quantifying errors in flow measurement using phase contrast magnetic resonance imaging: comparison of several boundary detection methods." Magn Reson Imaging 33(2): 185-193. [Open article]
  • Tao Y, Zhang X, Zivadinov R, Dwyer MG, Kennedy C, Bergsland N, Ramasamy D, Durfee J, Hojnacki D, Hayward B, Dangond F, Weinstock-Guttman B and Markovic-Plese S (2015). "Immunologic and MRI markers of the therapeutic effect of IFN-beta-1a in relapsing-remitting MS." Neurol Neuroimmunol Neuroinflamm 2(6): e176. [Open article]
  • Alexander JS, Chervenak R, Weinstock-Guttman B, Tsunoda I, Ramanathan M, Martinez N, Omura S, Sato F, Chaitanya GV, Minagar A, McGee J, Jennings MH, Monceaux C, Becker F, Cvek U, Trutschl M and Zivadinov R (2015). "Blood circulating microparticle species in relapsing-remitting and secondary progressive multiple sclerosis. A case-control, cross sectional study with conventional MRI and advanced iron content imaging outcomes." J Neurol Sci 355(1-2): 84-89. [Open article]
  • Varosanec M, Uher T, Horakova D, Hagemeier J, Bergsland N, Tyblova M, Seidl Z, Vaneckova M, Krasensky J, Dwyer MG, Havrdova E and Zivadinov R (2015). "Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome." AJNR Am J Neuroradiol 36(8): 1457-1464. [Open article]
  • Dwyer MG, Zivadinov R, Markovic-Plese S, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Weinstock-Guttman B, Hayward B and Dangond F (2015). "Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24weeks of therapy with subcutaneous interferon beta-1a three times weekly." J Neuroimmunol 281: 44-50. [Open article]
  • Hagemeier J, Tong O, Dwyer MG, Schweser F, Ramanathan M and Zivadinov R (2015). "Effects of diet on brain iron levels among healthy individuals: an MRI pilot study." Neurobiol Aging 36(4): 1678-1685. [Open article]
  • Dwyer MG, Zivadinov R, Tao Y, Zhang X, Kennedy C, Bergsland N, Ramasamy DP, Durfee J, Hojnacki D, Weinstock-Guttman B, Hayward B, Dangond F and Markovic-Plese S (2015). "Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial." BMC Neurol 15: 232. [Open article]
  • Graziano E, Hagemeier J, Weinstock-Guttman B, Ramasamy DP and Zivadinov R (2015). "Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients." Neuroimage Clin 9: 110-116. [Open article]
  • Malyavantham K, Weinstock-Guttman B, Suresh L, Zivadinov R, Shanahan T, Badgett D and Ramanathan M (2015). "Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis." PLoS One 10(6): e0129503. [Open article]
  • Narayanaswamy R, Iyer V, Khare P, Bodziak ML, Badgett D, Zivadinov R, Weinstock-Guttman B, Rideout TC, Ramanathan M and Browne RW (2015). "Simultaneous Determination of Oxysterols, Cholesterol and 25-Hydroxy-Vitamin D3 in Human Plasma by LC-UV-MS." PLoS One 10(4): e0123771. [Open article]
  • Schwartz CE, Ayandeh A, Ramanathan M, Benedict R, Dwyer MG, Weinstock-Guttman B and Zivadinov R (2015). "Reserve-building activities in multiple sclerosis patients and healthy controls: a descriptive study." BMC Neurol 15: 135. [Open article]

2014

  • Browne RW, Weinstock-Guttman B, Zivadinov R, Horakova D, Bodziak ML, Tamano-Blanco M, Badgett D, Tyblova M, Vaneckova M, Seidl Z, Krasensky J, Bergsland N, Ramasamy DP, Hagemeier J, Qu J, Havrdova E and Ramanathan M (2014). "Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study." J Steroid Biochem Mol Biol 143: 424-433. [Open article]
  • Uher T, Blahova-Dusankova J, Horakova D, Bergsland N, Tyblova M, Benedict RH, Kalincik T, Ramasamy DP, Seidl Z, Hagermeier J, Vaneckova M, Krasensky J, Havrdova E and Zivadinov R (2014). "Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome." J Neurol 261(9): 1735-1744. [Open article]
  • Uher T, Benedict RH, Horakova D, Bergsland N, Dusankova JB, Tyblova M, Ramasamy DP, Seidl Z, Vaneckova M, Krasensky J, Havrdova E and Zivadinov R (2014). "Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment." J Neurol Sci 347(1-2): 229-234. [Open article]
  • Hagemeier J, Heininen-Brown M, Gabelic T, Guttuso T, Jr., Silvestri N, Lichter D, Fugoso LE, Bergsland N, Carl E, Geurts JJ, Weinstock-Guttman B and Zivadinov R (2014). "Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders." AJNR Am J Neuroradiol 35(10): 1916-1923. [Open article]
  • Jacobsen C, Hagemeier J, Myhr KM, Nyland H, Lode K, Bergsland N, Ramasamy DP, Dalaker TO, Larsen JP, Farbu E and Zivadinov R (2014). "Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study." J Neurol Neurosurg Psychiatry 85(10): 1109-1115. [Open article]
  • Beggs CB, Magnano C, Shepherd SJ, Marr K, Valnarov V, Hojnacki D, Bergsland N, Belov P, Grisafi S, Dwyer MG, Carl E, Weinstock-Guttman B and Zivadinov R (2014). "Aqueductal cerebrospinal fluid pulsatility in healthy individuals is affected by impaired cerebral venous outflow." J Magn Reson Imaging 40(5): 1215-1222. [Open article]
  • Benedict RH, Morrow S, Rodgers J, Hojnacki D, Bucello MA, Zivadinov R and Weinstock-Guttman B (2014). "Characterizing cognitive function during relapse in multiple sclerosis." Mult Scler 20(13): 1745-1752. [Open article]
  • Zivadinov R, Bastianello S, Dake MD, Ferral H, Haacke EM, Haskal ZJ, Hubbard D, Liasis N, Mandato K, Sclafani S, Siddiqui AH, Simka M and Zamboni P (2014). "Recommendations for multimodal noninvasive and invasive screening for detection of extracranial venous abnormalities indicative of chronic cerebrospinal venous insufficiency: a position statement of the international society for neurovascular disease." J Vasc Interv Radiol 25(11): 1785-1794 e1717. [Open article]
  • Cappellani R, Bergsland N, Weinstock-Guttman B, Kennedy C, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Patti F and Zivadinov R (2014). "Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study." AJNR Am J Neuroradiol 35(5): 912-919. [Open article]
  • Pfordresher PQ, Mantell JT, Brown S, Zivadinov R and Cox JL (2014). "Brain responses to altered auditory feedback during musical keyboard production: an fMRI study." Brain Res 1556: 28-37. [Open article]
  • Cappellani R, Bergsland N, Weinstock-Guttman B, Kennedy C, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Patti F and Zivadinov R (2014). "Diffusion tensor MRI alterations of subcortical deep gray matter in clinically isolated syndrome." J Neurol Sci 338(1-2): 128-134. [Open article]
  • Goldberg H, Weinstock A, Bergsland N, Dwyer MG, Farooq O, Sazgar M, Poloni G, Treu C, Weinstock-Guttman B, Ramanathan M and Zivadinov R (2014). "MRI segmentation analysis in temporal lobe and idiopathic generalized epilepsy." BMC Neurol 14(1): 131. [Open article]
  • Siddiqui AH, Zivadinov R, Benedict RH, Karmon Y, Yu J, Hartney ML, Marr KL, Valnarov V, Kennedy CL, Ramanathan M, Ramasamy DP, Dolic K, Hojnacki DW, Carl E, Levy EI, Hopkins LN and Weinstock-Guttman B (2014). "Prospective randomized trial of venous angioplasty in MS (PREMiSe)." Neurology 83(5): 441-449. [Open article]
  • Donohue K, Cox JL, Dwyer MG, Aliotta R, Corwin M, Weinstock-Guttman B, Ann Yeh E and Zivadinov R (2014). "No regional gray matter atrophy differences between pediatric- and adult-onset relapsing-remitting multiple sclerosis." J Neuroimaging 24(1): 63-67. [Open article]
  • Chung CP, Beggs C, Wang PN, Bergsland N, Shepherd S, Cheng CY, Ramasamy DP, Dwyer MG, Hu HH and Zivadinov R (2014). "Jugular venous reflux and white matter abnormalities in Alzheimer's disease: a pilot study." J Alzheimers Dis 39(3): 601-609. [Open article]
  • Aliotta R, Cox JL, Donohue K, Weinstock-Guttman B, Yeh EA, Polak P, Dwyer MG and Zivadinov R (2014). "Tract-based spatial statistics analysis of diffusion-tensor imaging data in pediatric- and adult-onset multiple sclerosis." Hum Brain Mapp 35(1): 53-60. [Open article]
  • Gabelic T, Ramasamy DP, Weinstock-Guttman B, Hagemeier J, Kennedy C, Melia R, Hojnacki D, Ramanathan M and Zivadinov R (2014). "Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis." AJNR Am J Neuroradiol 35(1): 106-112. [Open article]
  • Gupta S, Zivadinov R, Ramasamy D and Ambrus JL, Jr. (2014). "Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature." Clin Rheumatol 33(12): 1829-1833. [Open article]
  • Mak E, Bergsland N, Dwyer MG, Zivadinov R and Kandiah N (2014). "Subcortical atrophy is associated with cognitive impairment in mild Parkinson disease: a combined investigation of volumetric changes, cortical thickness, and vertex-based shape analysis." AJNR Am J Neuroradiol 35(12): 2257-2264. [Open article]
  • Zivadinov R, Chin J, Horakova D, Bergsland N, Weinstock-Guttman B, Tamano-Blanco M, Badgett D, Hagemeier J, Tyblova M, Carl E, Krasensky J, Vaneckova M, Seidl Z, Dwyer MG, Havrdova E and Ramanathan M (2014). "Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: results from the multi-center set study." J Neuroimmunol 273(1-2): 58-64. [Open article]
  • Barnett Y, Sutton IJ, Ghadiri M, Masters L, Zivadinov R and Barnett MH (2014). "Conventional and Advanced Imaging in Neuromyelitis Optica." AJNR Am J Neuroradiol 35(8): 1458-1466. [Open article]
  • Browne RW, Weinstock-Guttman B, Horakova D, Zivadinov R, Bodziak ML, Tamano-Blanco M, Badgett D, Tyblova M, Vaneckova M, Seidl Z, Krasensky J, Bergsland N, Ramasamy DP, Hagemeier J, Havrdova E and Ramanathan M (2014). "Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes." J Neurol Neurosurg Psychiatry 85(8): 859-864. [Open article]
  • Zivadinov R, Bergsland N, Cappellani R, Hagemeier J, Melia R, Carl E, Dwyer MG, Lincoff N, Weinstock-Guttman B and Ramanathan M (2014). "Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients." Eur J Neurol 21(8): 1137-e1161. [Open article]
  • Dwyer MG, Bergsland N and Zivadinov R (2014). "Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model." Neuroimage 90: 207-217. [Open article]
  • Uher T, Horakova D, Bergsland N, Tyblova M, Ramasamy DP, Seidl Z, Vaneckova M, Krasensky J, Havrdova E and Zivadinov R (2014). "MRI correlates of disability progression in patients with CIS over 48 months." Neuroimage Clin 6: 312-319. [Open article]
  • Zivadinov R, Dwyer MG, Markovic-Plese S, Kennedy C, Bergsland N, Ramasamy DP, Durfee J, Hojnacki D, Hayward B, Dangond F and Weinstock-Guttman B (2014). "Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study." PLoS One 9(3): e91098. [Open article]

2013

  • Booth AJ, Rodgers JD, Schwartz CE, Quaranto BR, Weinstock-Guttman B, Zivadinov R and Benedict RH (2013). "Active Cognitive Reserve Influences the Regional Atrophy to Cognition Link in Multiple Sclerosis." J Int Neuropsychol Soc: 1-6. [Open article]
  • Wack DS, Dwyer MG, Bergsland N, Ramasamy D, Di Perri C, Ranza L, Hussein S, Magnano C, Seals K and Zivadinov R (2013). "Improved operator agreement and efficiency using the minimum area contour change method for delineation of hyperintense multiple sclerosis lesions on FLAIR MRI." BMC Med Imaging 13(1): 29. [Open article]
  • Kardys A, Weinstock-Guttman B, Dillon M, Masud MW, Weinstock N, Mahfooz N, Lang JK, Weinstock A, Lincoff N, Zivadinov R and Ramanathan M (2013). "Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis." Eur J Neurol 20(9): 1264-1271. [Open article]
  • Zivadinov R, Havrdova E, Bergsland N, Tyblova M, Hagemeier J, Seidl Z, Dwyer MG, Vaneckova M, Krasensky J, Carl E, Kalincik T and Horakova D (2013). "Thalamic atrophy is associated with development of clinically definite multiple sclerosis." Radiology 268(3): 831-841. [Open article]
  • Beggs C, Chung CP, Bergsland N, Wang PN, Shepherd S, Cheng CY, Dwyer MG, Hu HH and Zivadinov R (2013). "Jugular venous reflux and brain parenchyma volumes in elderly patients with mild cognitive impairment and Alzheimer's disease." BMC Neurol 13(1): 157. [Open article]
  • Zivadinov R, Karmon Y, Dolic K, Hagemeier J, Marr K, Valnarov V, Kennedy CL, Hojnacki D, Carl EM, Hopkins LN, Levy EI, Weinstock-Guttman B and Siddiqui AH (2013). "Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: results of the PREMiSe pilot study." BMC Neurol 13(1): 151. [Open article]
  • Weinstock-Guttman B, Horakova D, Zivadinov R, Tamano-Blanco M, Badgett D, Tyblova M, Vaneckova M, Seidl Z, Krasensky J, Bergsland N, Ramasamy DP, Hagemeier J, Havrdova E and Ramanathan M (2013). "Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromes." J Neuroimmunol 263(1-2): 121-127. [Open article]
  • Chaitanya GV, Omura S, Sato F, Martinez NE, Minagar A, Ramanathan M, Guttman BW, Zivadinov R, Tsunoda I and Alexander JS (2013). "Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature." J Neuroinflammation 10(1): 125. [Open article]
  • Benedict RH, Hulst HE, Bergsland N, Schoonheim MM, Dwyer MG, Weinstock-Guttman B, Geurts JJ and Zivadinov R (2013). "Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients." Mult Scler 19(11): 1478-1484. [Open article]
  • Karmon Y, Zivadinov R, Weinstock-Guttman B, Marr K, Valnarov V, Dolic K, Kennedy CL, Hojnacki D, Carl EM, Hagemeier J, Hopkins LN, Levy EI and Siddiqui AH (2013). "Comparison of intravascular ultrasound with conventional venography for detection of extracranial venous abnormalities indicative of chronic cerebrospinal venous insufficiency." J Vasc Interv Radiol 24(10): 1487-1498 e1481. [Open article]
  • Zivadinov R, Bergsland N, Dolezal O, Hussein S, Seidl Z, Dwyer MG, Vaneckova M, Krasensky J, Potts JA, Kalincik T, Havrdova E and Horakova D (2013). "Evolution of Cortical and Thalamus Atrophy and Disability Progression in Early Relapsing-Remitting MS during 5 Years." AJNR Am J Neuroradiol 34(10): 1931-1939. [Open article]
  • Zivadinov R, Treu CN, Weinstock-Guttman B, Turner C, Bergsland N, O'Connor K, Dwyer MG, Carl E, Ramasamy DP, Qu J and Ramanathan M (2013). "Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis." J Neurol Neurosurg Psychiatry 84(10): 1075-1081. [Open article]
  • Chitnis T, Guttmann CR, Zaitsev A, Musallam A, Weinstock-Guttmann B, Yeh A, Rodriguez M, Ness J, Gorman M, Healy BC, Kuntz N, Chabas D, Strober JB, Waubant E, Krupp L, Pelletier D, Erickson B, Bergsland N and Zivadinov R (2013). "Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study." BMC Neurol 13(1): 173. [Open article]
  • Hagemeier J, Dwyer MG, Bergsland N, Schweser F, Magnano CR, Heininen-Brown M, Ramasamy DP, Carl E, Kennedy C, Melia R, Polak P, Deistung A, Geurts JJ, Reichenbach JR and Zivadinov R (2013). "Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals." AJNR Am J Neuroradiol 34(11): 2144-2151. [Open article]
  • Weinstock-Guttman B, Zivadinov R, Horakova D, Havrdova E, Qu J, Shyh G, Lakota E, O'Connor K, Badgett D, Tamano-Blanco M, Tyblova M, Hussein S, Bergsland N, Willis L, Krasensky J, Vaneckova M, Seidl Z and Ramanathan M (2013). "Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event." J Neurol Neurosurg Psychiatry 84(11): 1186-1191. [Open article]
  • Schwendimann RN, Harris MK, Elliott DG, Menon U, Gonzalez-Toledo E, Zivadinov R, Pressly TA, Kelley RE, Hoque R, Fowler M, Maghzi AH, Etemadifar M, Saadatnia M and Minagar A (2013). "Neurosarcoidosis: clinical features, diagnosis, and management." Am J Ther 20(3): 292-299. [Open article]
  • Alves G, Pedersen KF, Bloem BR, Blennow K, Zetterberg H, Borm GF, Dalaker TO, Beyer MK, Aarsland D, Andreasson U, Lange J, Tysnes OB, Zivadinov R and Larsen JP (2013). "Cerebrospinal fluid amyloid-beta and phenotypic heterogeneity in de novo Parkinson's disease." J Neurol Neurosurg Psychiatry 84(5): 537-543. [Open article]
  • Khan O, Rieckmann P, Boyko A, Selmaj K, Zivadinov R and Group GS (2013). "Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis." Ann Neurol 73(6): 705-713. [Open article]
  • Zivadinov R, Magnano C, Galeotti R, Schirda C, Menegatti E, Weinstock-Guttman B, Marr K, Bartolomei I, Hagemeier J, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Beggs C, Salvi F and Zamboni P (2013). "Changes of cine cerebrospinal fluid dynamics in patients with multiple sclerosis treated with percutaneous transluminal angioplasty: a case-control study." J Vasc Interv Radiol 24(6): 829-838. [Open article]
  • Zivadinov R, Shucard JL, Hussein S, Durfee J, Cox JL, Bergsland N, Dwyer MG, Benedict RH, Ambrus J and Shucard DW (2013). "Multimodal imaging in systemic lupus erythematosus patients with diffuse neuropsychiatric involvement." Lupus 22(7): 675-683. [Open article]
  • Zivadinov R and Weinstock-Guttman B (2013). "Funding CCSVI research is/was a waste of valuable time, money and intellectual energy: no." Mult Scler 19(7): 858-860. [Open article]
  • Leddy JJ, Cox JL, Baker JG, Wack DS, Pendergast DR, Zivadinov R and Willer B (2013). "Exercise treatment for postconcussion syndrome: a pilot study of changes in functional magnetic resonance imaging activation, physiology, and symptoms." J Head Trauma Rehabil 28(4): 241-249. [Open article]
  • Benedict RH, Weinstock-Guttmam B, Marr K, Valnarov V, Kennedy C, Carl E, Brooks C, Hojnacki D and Zivadinov R (2013). "Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis." BMC Med 11(1): 167. [Open article]
  • Minagar A, Barnett MH, Benedict RH, Pelletier D, Pirko I, Sahraian MA, Frohman E and Zivadinov R (2013). "The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects." Neurology 80(2): 210-219. [Open article]
  • Dolezal O, Gabelic T, Horakova D, Bergsland N, Dwyer MG, Seidl Z, Krasensky J, Ramasamy DP, Vaneckova M, Havrdova E and Zivadinov R (2013). "Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: Results of a 5-year follow-up study." Clin Neurol Neurosurg 115 Suppl 1: S42-48. [Open article]
  • Gabelic T, Weinstock-Guttman B, Melia R, Lincoff N, Masud MW, Kennedy C, Brinar V, Ramasamy DP, Carl E, Bergsland N, Ramanathan M and Zivadinov R (2013). "Retinal nerve fiber thickness and MRI white matter abnormalities in healthy relatives of multiple sclerosis patients." Clin Neurol Neurosurg 115 Suppl 1: S49-54. [Open article]
  • Clifford DB, Nath A, Cinque P, Brew BJ, Zivadinov R, Gorelik L, Zhao Z and Duda P (2013). "A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes." J Neurovirol 19(4): 351-358. [Open article]
  • Tipirneni A, Weinstock-Guttman B, Ramanathan M, Abdelrahman N, Hussein S, Hagemeier J, Durfee J, Teter BE, Hojnacki D, Dwyer MG and Zivadinov R (2013). "MRI characteristics of familial and sporadic multiple sclerosis patients." Mult Scler 19(9): 1145-1152. [Open article]
  • Benedict RH, Schwartz CE, Duberstein P, Healy B, Hoogs M, Bergsland N, Dwyer MG, Weinstock-Guttman B and Zivadinov R (2013). "Influence of personality on the relationship between gray matter volume and neuropsychiatric symptoms in multiple sclerosis." Psychosom Med 75(3): 253-261. [Open article]
  • Hagemeier J, Yeh EA, Brown MH, Bergsland N, Dwyer MG, Carl E, Weinstock-Guttman B and Zivadinov R (2013). "Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis." Mult Scler 19(5): 567-576. [Open article]
  • Chung CP, Cheng CY, Zivadinov R, Chen WC, Sheng WY, Lee YC, Hu HH, Hsu HY and Yang KY (2013). "Jugular venous reflux and plasma endothelin-1 are associated with cough syncope: a case control pilot study." BMC Neurol 13: 9. [Open article]
  • Dolic K, Siddiqui AH, Karmon Y, Marr K and Zivadinov R (2013). "The role of noninvasive and invasive diagnostic imaging techniques for detection of extra-cranial venous system anomalies and developmental variants." BMC Med 11(1): 155. [Open article]
  • Hagemeier J, Weinstock-Guttman B, Heininen-Brown M, Poloni GU, Bergsland N, Schirda C, Magnano CR, Kennedy C, Carl E, Dwyer MG, Minagar A and Zivadinov R (2013). "Gray matter SWI-filtered phase and atrophy are linked to disability in MS." Front Biosci (Elite Ed) 5: 525-532. [Open article]
  • Horakova D, Zivadinov R, Weinstock-Guttman B, Havrdova E, Qu J, Tamano-Blanco M, Badgett D, Tyblova M, Bergsland N, Hussein S, Willis L, Krasensky J, Vaneckova M, Seidl Z, Lelkova P, Dwyer MG, Zhang M, Yu H, Duan X, Kalincik T and Ramanathan M (2013). "Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study." PLoS One 8(1): e53996. [Open article]
  • Zivadinov R (2013). "Is there a link between the extracranial venous system and central nervous system pathology?" BMC Med 11(1): 259. [Open article]
  • Zivadinov R and Chung CP (2013). "Potential involvement of the extracranial venous system in central nervous system disorders and aging." BMC Med 11(1): 260. [Open article]
  • Zivadinov R, Tekwe C, Bergsland N, Dolezal O, Havrdova E, Krasensky J, Dwyer MG, Seidl Z, Ramasamy DP, Vaneckova M and Horakova D (2013). "Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study." Mult Scler Int 2013: 231345. [Open article]

2012

  • Bergsland N, Horakova D, Dwyer MG, Dolezal O, Seidl ZK, Vaneckova M, Krasensky J, Havrdova E and Zivadinov R (2012). "Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis." AJNR Am J Neuroradiol 33(8): 1573-1578. [Open article]
  • Hagemeier J, Weinstock-Guttman B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Magnano C, Hojnacki D, Dwyer MG and Zivadinov R (2012). "Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy." AJNR Am J Neuroradiol 33(8): 1596-1601. [Open article]
  • Polak P, Magnano C, Zivadinov R and Poloni G (2012). "3D FLAIRED: 3D fluid attenuated inversion recovery for enhanced detection of lesions in multiple sclerosis." Magn Reson Med 68(3): 874-881. [Open article]
  • Beggs CB, Shepherd SJ, Dwyer MG, Polak P, Magnano C, Carl E, Poloni GU, Weinstock-Guttman B and Zivadinov R (2012). "Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis." Neurol Res 34(8): 793-801. [Open article]
  • Dolic K, Weinstock-Guttman B, Marr K, Valnarov V, Carl E, Hagemeier J, Kennedy C, Kilanowski C, Hojnacki D, Ramanathan M and Zivadinov R (2012). "Heart disease, overweight, and cigarette smoking are associated with increased prevalence of extra-cranial venous abnormalities." Neurol Res 34(8): 819-827. [Open article]
  • Karmon Y, Ramanathan M, Minagar A, Zivadinov R and Weinstock-Guttman B (2012). "Arterial, venous and other vascular risk factors in multiple sclerosis." Neurol Res 34(8): 754-760. [Open article]
  • Magnano C, Schirda C, Weinstock-Guttman B, Wack DS, Lindzen E, Hojnacki D, Bergsland N, Kennedy C, Belov P, Dwyer MG, Poloni GU, Beggs CB and Zivadinov R (2012). "Cine cerebrospinal fluid imaging in multiple sclerosis." J Magn Reson Imaging 36(4): 825-834. [Open article]
  • Zivadinov R, Alexander SJ and Minagar A (2012). "Vascular pathology of multiple sclerosis." Neurol Res 34(8): 735-737. [Open article]
  • Zivadinov R, Ramanathan M, Ambrus J, Hussein S, Ramasamy DP, Dwyer MG, Bergsland N, Minagar A and Weinstock-Guttman B (2012). "Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study." Neurol Res 34(8): 761-769. [Open article]
  • Zivadinov R and Weinstock-Guttman B (2012). "Role of venoplasty for treatment of multiple sclerosis: value of open-label studies and surrogate treatment outcomes." J Vasc Interv Radiol 23(10): 1308-1310. [Open article]
  • Mokin M, Kass-Hout T, Kass-Hout O, Zivadinov R and Mehta B (2012). "Blood pressure management and evolution of thrombolysis-associated intracerebral hemorrhage in acute ischemic stroke." J Stroke Cerebrovasc Dis 21(8): 852-859. [Open article]
  • Zivadinov R, Cutter G, Marr K, Ramanathan M, Benedict RH, Bergsland N, Morgan C, Carl E, Hojnacki D, Yeh EA, Willis L, Cherneva M, Kennedy C, Dwyer MG and Weinstock-Guttman B (2012). "No association between conventional brain MR imaging and chronic cerebrospinal venous insufficiency in multiple sclerosis." AJNR Am J Neuroradiol 33(10): 1913-1917. [Open article]
  • Hagemeier J, Heininen-Brown M, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Weinstock-Guttman B, Dwyer MG and Zivadinov R (2012). "Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study." J Magn Reson Imaging 36(1): 73-83. [Open article]
  • Zivadinov R, Heininen-Brown M, Schirda CV, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Hagemeier J, Benedict RH, Weinstock-Guttman B and Dwyer MG (2012). "Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study." Neuroimage 59(1): 331-339. [Open article]
  • Batista S, Zivadinov R, Hoogs M, Bergsland N, Heininen-Brown M, Dwyer MG, Weinstock-Guttman B and Benedict RH (2012). "Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis." J Neurol 259(1): 139-146. [Open article]
  • Dolic K, Marr K, Valnarov V, Dwyer MG, Carl E, Karmon Y, Kennedy C, Brooks C, Kilanowski C, Hunt K, Siddiqui AH, Hojnacki D, Weinstock-Guttman B and Zivadinov R (2012). "Intra- and extraluminal structural and functional venous anomalies in multiple sclerosis, as evidenced by 2 noninvasive imaging techniques." AJNR Am J Neuroradiol 33(1): 16-23. [Open article]
  • Zamboni P, Galeotti R, Weinstock-Guttman B, Kennedy C, Salvi F and Zivadinov R (2012). "Venous angioplasty in patients with multiple sclerosis: results of a pilot study." Eur J Vasc Endovasc Surg 43(1): 116-122. [Open article]
  • Zamboni P, Weinstock-Guttman B and Zivadinov R (2012). "Regarding CCSVI: is blinding the key?" Eur J Vasc Endovasc Surg 43(1): 126. [Open article]
  • Zivadinov R, Salvi F and Weinstock-Guttman B (2012). "Regarding CCSVI and MS: a never-ending story or a new chapter?" Eur J Vasc Endovasc Surg 43(1): 129-130. [Open article]
  • Foster M, Zivadinov R, Weinstock-Guttman B, Tamano-Blanco M, Badgett D, Carl E and Ramanathan M (2012). "Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis." J Neuroimmunol 243(1-2): 61-68. [Open article]
  • Dolic K, Marr K and Zivadinov R (2012). "Unclear value of positional MR angiography in evaluating cerebral venous outflow hemodynamics." AJNR Am J Neuroradiol 33(2): E30; author reply E31. [Open article]
  • Habib CA, Liu M, Bawany N, Garbern J, Krumbein I, Mentzel HJ, Reichenbach J, Magnano C, Zivadinov R and Haacke EM (2012). "Assessing abnormal iron content in the deep gray matter of patients with multiple sclerosis versus healthy controls." AJNR Am J Neuroradiol 33(2): 252-258. [Open article]
  • Hagemeier J, Geurts JJ and Zivadinov R (2012). "Brain iron accumulation in aging and neurodegenerative disorders." Expert Rev Neurother 12(12): 1467-1480. [Open article]
  • Zivadinov R, Dwyer MG, Hussein S, Carl E, Kennedy C, Andrews M, Hojnacki D, Heininen-Brown M, Willis L, Cherneva M, Bergsland N and Weinstock-Guttman B (2012). "Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNbeta-1a in multiple sclerosis." Mult Scler 18(8): 1125-1134. [Open article]
  • Livshits I, Hussein S, Kennedy C, Weinstock-Guttman B, Hojnacki D and Zivadinov R (2012). "Comparison of a 1.5T standard vs. 3T optimized protocols in multiple sclerosis patients." Minerva Med 103(2): 97-102. [Open article]
  • O'Connor K, Weinstock-Guttman B, Carl E, Kilanowski C, Zivadinov R and Ramanathan M (2012). "Patterns of dietary and herbal supplement use by multiple sclerosis patients." J Neurol 259(4): 637-644. [Open article]
  • Pirko I, Cardin R, Chen Y, Lohrey AK, Lindquist DM, Dunn RS, Zivadinov R and Johnson AJ (2012). "CMV infection attenuates the disease course in a murine model of multiple sclerosis." PLoS One 7(2): e32767. [Open article]
  • Wack DS, Dwyer MG, Bergsland N, Di Perri C, Ranza L, Hussein S, Ramasamy D, Poloni G and Zivadinov R (2012). "Improved assessment of multiple sclerosis lesion segmentation agreement via detection and outline error estimates." BMC Med Imaging 12: 17. [Open article]
  • Weinstock-Guttman B, Ramanathan M, Marr K, Hojnacki D, Benedict RH, Morgan C, Yeh EA, Carl E, Kennedy C, Reuther J, Brooks C, Hunt K, Elfadil M, Andrews M and Zivadinov R (2012). "Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis." BMC Neurol 12: 26. [Open article]
  • Zivadinov R, Hojnacki D, Hussein S, Bergsland N, Carl E, Durfee J, Dwyer MG, Kennedy C and Weinstock-Guttman B (2012). "Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study." Int J Mol Sci 13(5): 5659-5673. [Open article]
  • Zivadinov R, Hussein S, Bergsland N, Minagar A and Dwyer MG (2012). "Magnetization transfer imaging of acute black holes in patients on glatiramer acetate." Front Biosci (Elite Ed) 4: 1496-1504. [Open article]
  • Zivadinov R and Pirko I (2012). "Advances in understanding gray matter pathology in multiple sclerosis: are we ready to redefine disease pathogenesis?" BMC Neurol 12: 9. [Open article]

2011

  • Zivadinov R, Ramanathan M, Dolic K, Marr K, Karmon Y, Siddiqui AH, Benedict RH and Weinstock-Guttman B (2011). "Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives." Expert Rev Neurother 11(9): 1277-1294. [Open article]
  • Dake MD, Zivadinov R and Haacke EM (2011). "Chronic cerebrospinal venous insufficiency in multiple sclerosis: a historical perspective." Funct Neurol 26(4): 181-195. [Open article]
  • Dolic K, Marr K, Valnarov V, Dwyer MG, Carl E, Hagemeier J, Kennedy C, Brooks C, Kilanowski C, Hunt K, Hojnacki D, Weinstock-Guttman B and Zivadinov R (2011). "Sensitivity and specificity for screening of chronic cerebrospinal venous insufficiency using a multimodal non-invasive imaging approach in patients with multiple sclerosis." Funct Neurol 26(4): 205-214. [Open article]
  • Zivadinov R and Marr K (2011). "Comment on "Chronic cerebrospinal venous insufficiency: have we found the cause and cure of MS?"." Neurology 77(18): 1710; author reply 1710-1711. [Open article]
  • Valerio M, Liu HB, Heffner R, Zivadinov R, Ramanathan M, Weinstock-Guttman B and Awad AB (2011). "Phytosterols ameliorate clinical manifestations and inflammation in experimental autoimmune encephalomyelitis." Inflamm Res 60(5): 457-465. [Open article]
  • Zivadinov R, Galeotti R, Hojnacki D, Menegatti E, Dwyer MG, Schirda C, Malagoni AM, Marr K, Kennedy C, Bartolomei I, Magnano C, Salvi F, Weinstock-Guttman B and Zamboni P (2011). "Value of MR venography for detection of internal jugular vein anomalies in multiple sclerosis: a pilot longitudinal study." AJNR Am J Neuroradiol 32(5): 938-946. [Open article]
  • Benedict RH and Zivadinov R (2011). "Risk factors for and management of cognitive dysfunction in multiple sclerosis." Nat Rev Neurol 7(6): 332-342. [Open article]
  • Kister I, Chamot E, Bacon JH, Cutter G and Herbert J (2011). "Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium." Mult Scler 17(6): 725-733. [Open article]
  • Zivadinov R, Ramanathan M, Dwyer MG, Marr K, Benedict RH and Weinstock-Guttman B (2011). "Comment on "no evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset"." Ann Neurol 69(6): 1062-1063; author reply 1063. [Open article]
  • Zivadinov R, Marr K, Cutter G, Ramanathan M, Benedict RH, Kennedy C, Elfadil M, Yeh AE, Reuther J, Brooks C, Hunt K, Andrews M, Carl E, Dwyer MG, Hojnacki D and Weinstock-Guttman B (2011). "Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS." Neurology 77(2): 138-144. [Open article]
  • Antulov R, Carone DA, Bruce J, Yella V, Dwyer MG, Tjoa CW, Benedict RH and Zivadinov R (2011). "Regionally distinct white matter lesions do not contribute to regional gray matter atrophy in patients with multiple sclerosis." J Neuroimaging 21(3): 210-218. [Open article]
  • Horakova D, Zivadinov R, Weinstock-Guttman B, Havrdova E, Tamano-Blanco M, Tyblova M, Hussein S, Bergsland N, Willis L, Krasensky J, Vaneckova M, Seidl Z, Lelkova P and Ramanathan M (2011). "HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event." J Neuroimmunol 236(1-2): 76-80. [Open article]
  • Poloni G, Minagar A, Haacke EM and Zivadinov R (2011). "Recent developments in imaging of multiple sclerosis." Neurologist 17(4): 185-204. [Open article]
  • Dalaker TO, Zivadinov R, Ramasamy DP, Beyer MK, Alves G, Bronnick KS, Tysnes OB, Aarsland D and Larsen JP (2011). "Ventricular enlargement and mild cognitive impairment in early Parkinson's disease." Mov Disord 26(2): 297-301. [Open article]
  • Alexander JS, Zivadinov R, Maghzi AH, Ganta VC, Harris MK and Minagar A (2011). "Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms." Pathophysiology 18(1): 3-12. [Open article]
  • Minagar A and Zivadinov R (2011). "Pathophysiology of demyelinating disorders." Pathophysiology 18(1): 1-2. [Open article]
  • Ramasamy DP, Ramanathan M, Cox JL, Antulov R, Weinstock-Guttman B, Bergsland N, Benedict RH, Dwyer MG, Minagar A and Zivadinov R (2011). "Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry study." Pathophysiology 18(1): 53-60. [Open article]
  • Weinstock-Guttman B, Benedict RH, Tamano-Blanco M, Ramasamy DP, Stosic M, Polito J, Zivadinov R and Ramanathan M (2011). "The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis." Pathophysiology 18(1): 43-52. [Open article]
  • Weinstock-Guttman B, Zivadinov R, Qu J, Cookfair D, Duan X, Bang E, Bergsland N, Hussein S, Cherneva M, Willis L, Heininen-Brown M and Ramanathan M (2011). "Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients." J Neurol Neurosurg Psychiatry 82(2): 189-195. [Open article]
  • Zivadinov R, Hussein S, Stosic M, Durfee J, Cox JL, Hashmi K, Abdelrahman N, Garg N, Dwyer MG and Weinstock-Guttman B (2011). "Glatiramer acetate recovers microscopic tissue damage in patients with multiple sclerosis. A case-control diffusion imaging study." Pathophysiology 18(1): 61-68. [Open article]
  • Zivadinov R, Lopez-Soriano A, Weinstock-Guttman B, Schirda CV, Magnano CR, Dolic K, Kennedy CL, Brooks CL, Reuther JA, Hunt K, Andrews M, Dwyer MG and Hojnacki DW (2011). "Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects." Radiology 258(2): 562-570. [Open article]
  • Weinstock-Guttman B, Zivadinov R and Ramanathan M (2011). "Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis." J Neurol Sci 311(1-2): 86-91. [Open article]
  • Covey TJ, Zivadinov R, Shucard JL and Shucard DW (2011). "Information processing speed, neural efficiency, and working memory performance in multiple sclerosis: differential relationships with structural magnetic resonance imaging." J Clin Exp Neuropsychol 33(10): 1129-1145. [Open article]
  • Dolic K, Weinstock-Guttman B, Marr K, Valnarov V, Carl E, Hagemeier J, Brooks C, Kilanowski C, Hojnacki D, Ramanathan M and Zivadinov R (2011). "Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large cohort of volunteers." PLoS One 6(11): e28062. [Open article]
  • Weinstock-Guttman B, Zivadinov R, Cutter G, Tamano-Blanco M, Marr K, Badgett D, Carl E, Elfadil M, Kennedy C, Benedict RH and Ramanathan M (2011). "Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patients." PLoS One 6(2): e16802. [Open article]
  • Weinstock-Guttman B, Zivadinov R, Mahfooz N, Carl E, Drake A, Schneider J, Teter B, Hussein S, Mehta B, Weiskopf M, Durfee J, Bergsland N and Ramanathan M (2011). "Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis." J Neuroinflammation 8: 127. [Open article]
  • Zamboni P, Menegatti E, Weinstock-Guttman B, Dwyer MG, Schirda CV, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Bergsland N, Magnano C, Bartolomei I, Salvi F and Zivadinov R (2011). "Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report." BMC Med 9: 22. [Open article]
  • Zivadinov R, Poloni GU, Marr K, Schirda CV, Magnano CR, Carl E, Bergsland N, Hojnacki D, Kennedy C, Beggs CB, Dwyer MG and Weinstock-Guttman B (2011). "Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency." BMC Neurol 11: 128. [Open article]
  • Zivadinov R, Weinstock-Guttman B and Pirko I (2011). "Iron deposition and inflammation in multiple sclerosis. Which one comes first?" BMC Neurosci 12: 60. [Open article]

2010

  • Morrow SA, Drake A, Zivadinov R, Munschauer F, Weinstock-Guttman B and Benedict RH (2010). "Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline." Clin Neuropsychol 24(7): 1131-1145. [Open article]
  • Minagar A, Alexander JS, Sahraian MA and Zivadinov R (2010). "Alemtuzumab and multiple sclerosis: therapeutic application." Expert Opin Biol Ther 10(3): 421-429. [Open article]
  • Kister I, Chamot E, Bacon JH, Niewczyk PM, De Guzman RA, Apatoff B, Coyle P, Goodman AD, Gottesman M, Granger C, Jubelt B, Krupp L, Lenihan M, Lublin F, Mihai C, Miller A, Munschauer FE, 3rd, Perel AB, Teter BE, Weinstock-Guttman B, Zivadinov R and Herbert J (2010). "Rapid disease course in African Americans with multiple sclerosis." Neurology 75(3): 217-223. [Open article]
  • Frohman EM, Cutter G, Remington G, Gao H, Rossman H, Weinstock-Guttman B, Durfee JE, Conger A, Carl E, Treadaway K, Lindzen E, Salter A, Frohman TC, Shah A, Bates A, Cox JL, Dwyer MG, Stuve O, Greenberg BM, Racke MK and Zivadinov R (2010). "A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis." Ther Adv Neurol Disord 3(1): 15-28. [Open article]
  • Stosic M, Ambrus J, Garg N, Weinstock-Guttman B, Ramanathan M, Kalman B, Minagar A, Munschauer FE, Galey TM, Hussein S, Bakshi R and Zivadinov R (2010). "MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis." J Neurol 257(1): 63-71. [Open article]
  • Weinstock-Guttman B, Ramanathan M, Hashmi K, Abdelrahman N, Hojnacki D, Dwyer MG, Hussein S, Bergsland N, Munschauer FE and Zivadinov R (2010). "Increased tissue damage and lesion volumes in African Americans with multiple sclerosis." Neurology 74(7): 538-544. [Open article]
  • Dalaker TO, Zivadinov R, Larsen JP, Beyer MK, Cox JL, Alves G, Bronnick K, Tysnes OB, Antulov R, Dwyer MG and Aarsland D (2010). "Gray matter correlations of cognition in incident Parkinson's disease." Mov Disord 25(5): 629-633. [Open article]
  • Hojnacki D, Zamboni P, Lopez-Soriano A, Galleotti R, Menegatti E, Weinstock-Guttman B, Schirda C, Magnano C, Malagoni AM, Kennedy C, Bartolomei I, Salvi F and Zivadinov R (2010). "Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls." Int Angiol 29(2): 127-139. [Open article]
  • Zamboni P, Menegatti E, Weinstock-Guttman B, Schirda C, Cox JL, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Dwyer MG, Bergsland N, Galeotti R, Hussein S, Bartolomei I, Salvi F, Ramanathan M and Zivadinov R (2010). "CSF dynamics and brain volume in multiple sclerosis are associated with extracranial venous flow anomalies: a pilot study." Int Angiol 29(2): 140-148. [Open article]
  • Zivadinov R, Schirda C, Dwyer MG, Haacke ME, Weinstock-Guttman B, Menegatti E, Heininen-Brown M, Magnano C, Malagoni AM, Wack DS, Hojnacki D, Kennedy C, Carl E, Bergsland N, Hussein S, Poloni G, Bartolomei I, Salvi F and Zamboni P (2010). "Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study." Int Angiol 29(2): 158-175. [Open article]
  • Horakova D, Kyr M, Havrdova E, Dolezal O, Lelkova P, Pospisilova L, Bergsland N, Dwyer MG, Cox JL, Hussein S, Seidl Z, Vaneckova M, Krasensky J and Zivadinov R (2010). "Apolipoprotein E epsilon4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study." Folia Biol (Praha) 56(6): 242-251. [Open article]
  • Horstman LL, Jy W, Ahn YS, Zivadinov R, Maghzi AH, Etemadifar M, Steven Alexander J and Minagar A (2010). "Role of platelets in neuroinflammation: a wide-angle perspective." J Neuroinflammation 7: 10. [Open article]

2009

  • Pirko I and Zivadinov R (2009). "Transcranial sonography of deep gray nuclei: a new outcome measure in multiple sclerosis?" Neurology 73(13): 1006-1007. [Open article]
  • Dalaker TO, Larsen JP, Dwyer MG, Aarsland D, Beyer MK, Alves G, Bronnick K, Tysnes OB and Zivadinov R (2009). "White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease." Neuroimage 47(4): 2083-2089. [Open article]
  • Di Perri C, Dwyer MG, Wack DS, Cox JL, Hashmi K, Saluste E, Hussein S, Schirda C, Stosic M, Durfee J, Poloni GU, Nayyar N, Bergamaschi R and Zivadinov R (2009). "Signal abnormalities on 1.5 and 3 Tesla brain MRI in multiple sclerosis patients and healthy controls. A morphological and spatial quantitative comparison study." Neuroimage 47(4): 1352-1362. [Open article]
  • Dalaker TO, Larsen JP, Bergsland N, Beyer MK, Alves G, Dwyer MG, Tysnes OB, Benedict RH, Kelemen A, Bronnick K and Zivadinov R (2009). "Brain atrophy and white matter hyperintensities in early Parkinson's disease(a)." Mov Disord 24(15): 2233-2241. [Open article]
  • Antulov R, Weinstock-Guttman B, Cox JL, Hussein S, Durfee J, Caiola C, Dwyer MG, Bergsland N, Abdelrahman N, Stosic M, Hojnacki D, Munschauer FE, Miletic D and Zivadinov R (2009). "Gender-related differences in MS: a study of conventional and nonconventional MRI measures." Mult Scler 15(3): 345-354. [Open article]
  • Zivadinov R, Zorzon M, Weinstock-Guttman B, Serafin M, Bosco A, Bratina A, Maggiore C, Grop A, Tommasi MA, Srinivasaraghavan B and Ramanathan M (2009). "Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis." J Neurol Neurosurg Psychiatry 80(6): 620-625. [Open article]
  • Zamboni P, Menegatti E, Weinstock-Guttman B, Schirda C, Cox JL, Malagoni AM, Hojanacki D, Kennedy C, Carl E, Dwyer MG, Bergsland N, Galeotti R, Hussein S, Bartolomei I, Salvi F and Zivadinov R (2009). "The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics." Funct Neurol 24(3): 133-138. [Open article]
  • Dwyer M, Bergsland N, Hussein S, Durfee J, Wack D and Zivadinov R (2009). "A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio." J Neurol Sci 282(1-2): 86-95. [Open article]
  • Frohman EM, Dwyer MG, Frohman T, Cox JL, Salter A, Greenberg BM, Hussein S, Conger A, Calabresi P, Balcer LJ and Zivadinov R (2009). "Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study." J Neurol Sci 282(1-2): 96-105. [Open article]
  • Geurts JJ, Stys PK, Minagar A, Amor S and Zivadinov R (2009). "Gray matter pathology in (chronic) MS: modern views on an early observation." J Neurol Sci 282(1-2): 12-20. [Open article]
  • Horakova D, Dwyer MG, Havrdova E, Cox JL, Dolezal O, Bergsland N, Rimes B, Seidl Z, Vaneckova M and Zivadinov R (2009). "Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study." J Neurol Sci 282(1-2): 112-119. [Open article]
  • Ramasamy DP, Benedict RH, Cox JL, Fritz D, Abdelrahman N, Hussein S, Minagar A, Dwyer MG and Zivadinov R (2009). "Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study." J Neurol Sci 282(1-2): 47-54. [Open article]
  • Zivadinov R and Minagar A (2009). "Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach." J Neurol Sci 282(1-2): 1-4. [Open article]
  • Zivadinov R (2009). "Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials." Methods Find Exp Clin Pharmacol 31(1): 29-40. [Open article]
  • Benedict RH, Ramasamy D, Munschauer F, Weinstock-Guttman B and Zivadinov R (2009). "Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy." J Neurol Neurosurg Psychiatry 80(2): 201-206. [Open article]
  • Patrick E, Christodoulou C, Krupp LB and New York State MSC (2009). "Longitudinal correlates of fatigue in multiple sclerosis." Mult Scler 15(2): 258-261. [Open article]
  • Yeh EA, Weinstock-Guttman B, Ramanathan M, Ramasamy DP, Willis L, Cox JL and Zivadinov R (2009). "Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis." Brain 132(Pt 12): 3392-3400. [Open article]
  • Zivadinov R, Weinstock-Guttman B, Hashmi K, Abdelrahman N, Stosic M, Dwyer M, Hussein S, Durfee J and Ramanathan M (2009). "Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis." Neurology 73(7): 504-510. [Open article]
  • Havrdova E, Zivadinov R, Krasensky J, Dwyer MG, Novakova I, Dolezal O, Ticha V, Dusek L, Houzvickova E, Cox JL, Bergsland N, Hussein S, Svobodnik A, Seidl Z, Vaneckova M and Horakova D (2009). "Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis." Mult Scler 15(8): 965-976. [Open article]
  • Zivadinov R, Weinstock-Guttman B, Zorzon M, Uxa L, Serafin M, Bosco A, Bratina A, Maggiore C, Grop A, Tommasi MA, Srinivasaraghavan B and Ramanathan M (2009). "Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis." J Neuroimmunol 209(1-2): 123-130. [Open article]
  • Salter AR, Conger A, Frohman TC, Zivadinov R, Eggenberger E, Calabresi P, Cutter G, Balcer L and Frohman EM (2009). "Retinal architecture predicts pupillary reflex metrics in MS." Mult Scler 15(4): 479-486. [Open article]
  • Di Perri C, Dalaker TO, Beyer MK and Zivadinov R (2009). "Neuroimaging of cognitive impairments in vascular disease." Int Rev Neurobiol 84: 49-80. [Open article]
  • Horstman LL, Jy W, Bidot CJ, Ahn YS, Kelley RE, Zivadinov R, Maghzi AH, Etemadifar M, Mousavi SA and Minagar A (2009). "Antiphospholipid antibodies: paradigm in transition." J Neuroinflammation 6: 3. [Open article]

2008

  • Weinstock-Guttman B, Miller C, Yeh E, Stosic M, Umhauer M, Batra N, Munschauer F, Zivadinov R and Ramanathan M (2008). "Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica." Mult Scler 14(8): 1061-1067. [Open article]
  • Weinstock-Guttman B, Ramanathan M and Zivadinov R (2008). "Interferon-beta treatment for relapsing multiple sclerosis." Expert Opin Biol Ther 8(9): 1435-1447. [Open article]
  • Dwyer MG, Bergsland N, Saluste E, Sharma J, Jaisani Z, Durfee J, Abdelrahman N, Minagar A, Hoque R, Munschauer FE, 3rd and Zivadinov R (2008). "Application of hidden Markov random field approach for quantification of perfusion/diffusion mismatch in acute ischemic stroke." Neurol Res 30(8): 827-834. [Open article]
  • Zivadinov R, Bergsland N, Stosic M, Sharma J, Nussenbaum F, Durfee J, Hani N, Abdelrahman N, Jaisani Z, Minagar A, Hoque R, Munschauer FE, 3rd and Dwyer MG (2008). "Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis." Neurol Res 30(8): 816-826. [Open article]
  • Grazioli E, Zivadinov R, Weinstock-Guttman B, Lincoff N, Baier M, Wong JR, Hussein S, Cox JL, Hojnacki D and Ramanathan M (2008). "Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis." J Neurol Sci 268(1-2): 12-17. [Open article]
  • Zivadinov R, Stosic M, Cox JL, Ramasamy DP and Dwyer MG (2008). "The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome." J Neurol 255 Suppl 1: 61-74. [Open article]
  • Benedict RH, Shucard JL, Zivadinov R and Shucard DW (2008). "Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis." Neuropsychol Rev 18(2): 149-166. [Open article]
  • Zivadinov R, Reder AT, Filippi M, Minagar A, Stuve O, Lassmann H, Racke MK, Dwyer MG, Frohman EM and Khan O (2008). "Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis." Neurology 71(2): 136-144. [Open article]
  • Benedict RH, Hussein S, Englert J, Dwyer MG, Abdelrahman N, Cox JL, Munschauer FE, Weinstock-Guttman B and Zivadinov R (2008). "Cortical atrophy and personality in multiple sclerosis." Neuropsychology 22(4): 432-441. [Open article]
  • Sternberg Z, Weinstock-Guttman B, Hojnacki D, Zamboni P, Zivadinov R, Chadha K, Lieberman A, Kazim L, Drake A, Rocco P, Grazioli E and Munschauer F (2008). "Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity." Mult Scler 14(6): 759-763. [Open article]
  • Frohman EM, Costello F, Stuve O, Calabresi P, Miller DH, Hickman SJ, Sergott R, Conger A, Salter A, Krumwiede KH, Frohman TC, Balcer L and Zivadinov R (2008). "Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis." Arch Neurol 65(1): 26-35. [Open article]
  • Zivadinov R, Banas AC, Yella V, Abdelrahman N, Weinstock-Guttman B and Dwyer MG (2008). "Comparison of three different methods for measurement of cervical cord atrophy in multiple sclerosis." AJNR Am J Neuroradiol 29(2): 319-325. [Open article]
  • Zivadinov R and Cox JL (2008). "Is functional MRI feasible for multi-center studies on multiple sclerosis?" Eur J Neurol 15(2): 109-110. [Open article]
  • Zivadinov R, Munschauer FE, Ramanathan M, Benedict RH and Weinstock-Guttman B (2008). "Clinical efficacy, effects on MRI and tolerability of weekly intramuscular interferon-beta-1a in patients with MS and CIS." Drugs Today (Barc) 44(8): 601-613. [Open article]
  • Zivadinov R, Zorzon M, De Masi R, Nasuelli D and Cazzato G (2008). "Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis." J Neurol Sci 267(1-2): 28-35. [Open article]
  • Horakova D, Cox JL, Havrdova E, Hussein S, Dolezal O, Cookfair D, Dwyer MG, Seidl Z, Bergsland N, Vaneckova M and Zivadinov R (2008). "Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study." J Neurol Neurosurg Psychiatry 79(4): 407-414. [Open article]
  • Tjoa CW, Benedict RH, Dwyer MG, Carone DA and Zivadinov R (2008). "Regional specificity of magnetization transfer imaging in multiple sclerosis." J Neuroimaging 18(2): 130-136. [Open article]
  • Brass SD, Zivadinov R and Bakshi R (2008). "Acute demyelinating optic neuritis: a review." Front Biosci 13: 2376-2390. [Open article]
  • Stuve O, Bennett JL, Hemmer B, Wiendl H, Racke MK, Bar-Or A, Hu W, Zivadinov R, Weber MS, Zamvil SS, Pacheco MF, Menge T, Hartung HP, Kieseier BC and Frohman EM (2008). "Pharmacological treatment of early multiple sclerosis." Drugs 68(1): 73-83. [Open article]

2007

  • Frohman EM, Shah A, Eggenberger E, Metz L, Zivadinov R and Stuve O (2007). "Corticosteroids for multiple sclerosis: I. Application for treating exacerbations." Neurotherapeutics 4(4): 618-626. [Open article]
  • Shah A, Eggenberger E, Zivadinov R, Stuve O and Frohman EM (2007). "Corticosteroids for multiple sclerosis: II. Application for disease-modifying effects." Neurotherapeutics 4(4): 627-632. [Open article]
  • Zivadinov R, Weinstock-Guttman B, Benedict R, Tamano-Blanco M, Hussein S, Abdelrahman N, Durfee J and Ramanathan M (2007). "Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor." Hum Mol Genet 16(22): 2659-2668. [Open article]
  • Zivadinov R (2007). "Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?" Neurology 68(22 Suppl 3): S72-82; discussion S91-76. [Open article]
  • Benedict RH and Zivadinov R (2007). "Reliability and validity of neuropsychological screening and assessment strategies in MS." J Neurol 254 Suppl 2: II22-II25. [Open article]
  • Zivadinov R, Locatelli L, Cookfair D, Srinivasaraghavan B, Bertolotto A, Ukmar M, Bratina A, Maggiore C, Bosco A, Grop A, Catalan M and Zorzon M (2007). "Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy." Mult Scler 13(4): 490-501. [Open article]
  • Tekok-Kilic A, Benedict RH, Weinstock-Guttman B, Dwyer MG, Carone D, Srinivasaraghavan B, Yella V, Abdelrahman N, Munschauer F, Bakshi R and Zivadinov R (2007). "Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis." Neuroimage 36(4): 1294-1300. [Open article]
  • Tavazzi E, Dwyer MG, Weinstock-Guttman B, Lema J, Bastianello S, Bergamaschi R, Cosi V, Benedict RH, Munschauer FE, 3rd and Zivadinov R (2007). "Quantitative diffusion weighted imaging measures in patients with multiple sclerosis." Neuroimage 36(3): 746-754. [Open article]
  • Benedict RH, Bruce J, Dwyer MG, Weinstock-Guttman B, Tjoa C, Tavazzi E, Munschauer FE and Zivadinov R (2007). "Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis." Mult Scler 13(6): 722-730. [Open article]
  • Garg N, Zivadinov R, Ramanathan M, Vasiliu I, Locke J, Watts K, Lema J, Rajeswary J, Munschauer FE, Ambrus J, Jr. and Weinstock-Guttman B (2007). "Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients." J Neuroimmunol 187(1-2): 159-165. [Open article]
  • Weinstock-Guttman B, Tamano-Blanco M, Bhasi K, Zivadinov R and Ramanathan M (2007). "Pharmacogenetics of MXA SNPs in interferon-beta treated multiple sclerosis patients." J Neuroimmunol 182(1-2): 236-239. [Open article]
  • Parmenter BA, Zivadinov R, Kerenyi L, Gavett R, Weinstock-Guttman B, Dwyer MG, Garg N, Munschauer F and Benedict RH (2007). "Validity of the Wisconsin Card Sorting and Delis-Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosis." J Clin Exp Neuropsychol 29(2): 215-223. [Open article]
  • Frohman EM and Zivadinov R (2007). "What you see is what you get: coupling function with structure in the visual system." Neurology 69(23): 2119-2120. [Open article]
  • Weinstock-Guttman B and Zivadinov R (2007). "New MRI criteria in the diagnosis of multiple sclerosis." Lancet Neurol 6(8): 664-665. [Open article]
  • Weinstock-Guttman B, Zivadinov R, Tamano-Blanco M, Abdelrahman N, Badgett D, Durfee J, Hussein S, Feichter J, Patrick K, Benedict R and Ramanathan M (2007). "Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis." J Neuroimmunol 188(1-2): 167-174. [Open article]
  • Dolezal O, Dwyer MG, Horakova D, Havrdova E, Minagar A, Balachandran S, Bergsland N, Seidl Z, Vaneckova M, Fritz D, Krasensky J and Zivadinov R (2007). "Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis." Int Rev Neurobiol 79: 475-489. [Open article]
  • Hoque R, Ledbetter C, Gonzalez-Toledo E, Misra V, Menon U, Kenner M, Rabinstein AA, Kelley RE, Zivadinov R and Minagar A (2007). "The role of quantitative neuroimaging indices in the differentiation of ischemia from demyelination: an analytical study with case presentation." Int Rev Neurobiol 79: 491-519. [Open article]
  • Zivadinov R and Cox JL (2007). "Neuroimaging in multiple sclerosis." Int Rev Neurobiol 79: 449-474. [Open article]
  • Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto S and Zorzon M (2007). "HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis." Int Rev Neurobiol 79: 521-535. [Open article]

2006

  • Zivadinov R and Sepcic J (2006). "[Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis]." Lijec Vjesn 128(9-10): 295-308. [Open article]
  • Benedict RH, Bruce JM, Dwyer MG, Abdelrahman N, Hussein S, Weinstock-Guttman B, Garg N, Munschauer F and Zivadinov R (2006). "Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis." Arch Neurol 63(9): 1301-1306. [Open article]
  • Frohman E, Costello F, Zivadinov R, Stuve O, Conger A, Winslow H, Trip A, Frohman T and Balcer L (2006). "Optical coherence tomography in multiple sclerosis." Lancet Neurol 5(10): 853-863. [Open article]
  • Sharma J, Zivadinov R, Jaisani Z, Fabiano AJ, Singh B, Horsfield MA and Bakshi R (2006). "A magnetization transfer MRI study of deep gray matter involvement in multiple sclerosis." J Neuroimaging 16(4): 302-310. [Open article]
  • Chadha K, Weinstock-Guttman B, Zivadinov R, Bhasi K, Muhitch J, Feichter J, Tamano-Blanco M, Abdelrahman N, Ambrus J, Sr., Munschauer F and Ramanathan M (2006). "Interferon inhibitory activity in patients with multiple sclerosis." Arch Neurol 63(11): 1579-1584. [Open article]
  • Tekok-Kilic A, Benedict RH and Zivadinov R (2006). "Update on the relationships between neuropsychological dysfunction and structural MRI in multiple sclerosis." Expert Rev Neurother 6(3): 323-331. [Open article]
  • Benedict RH and Zivadinov R (2006). "Predicting neuropsychological abnormalities in multiple sclerosis." J Neurol Sci 245(1-2): 67-72. [Open article]
  • Santos R, Weinstock-Guttman B, Tamano-Blanco M, Badgett D, Zivadinov R, Justinger T, Munschauer F, 3rd and Ramanathan M (2006). "Dynamics of interferon-beta modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-beta neutralizing antibodies." J Neuroimmunol 176(1-2): 125-133. [Open article]
  • Carone DA, Benedict RH, Dwyer MG, Cookfair DL, Srinivasaraghavan B, Tjoa CW and Zivadinov R (2006). "Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS." Neuroimage 29(2): 505-514. [Open article]
  • Carone DA, Benedict RH, Zivadinov R, Singh B and Ambrus JL (2006). "Progressive cerebral disease in lymphomatoid granulomatosis causes anterograde amnesia and neuropsychiatric disorder." J Neuroimaging 16(2): 163-166. [Open article]
  • Fritz DA, Dwyer MG, Bagnato F, Watts KL, Bratina A, Zorzon M, Durastanti V, Locatelli L, Millefiorini E and Zivadinov R (2006). "Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis." Neurol Res 28(3): 275-279. [Open article]
  • Frohman EM, Havrdova E, Lublin F, Barkhof F, Achiron A, Sharief MK, Stuve O, Racke MK, Steinman L, Weiner H, Olek M, Zivadinov R, Corboy J, Raine C, Cutter G, Richert J and Filippi M (2006). "Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis." Arch Neurol 63(4): 614-619. [Open article]
  • Zivadinov R, Nasuelli D, Tommasi MA, Serafin M, Bratina A, Ukmar M, Pirko I, Johnson AJ, Furlan C, Pozzi-Mucelli RS, Monti-Bragadin L, Grop A, Zambon M, Antonello RM, Cazzato G and Zorzon M (2006). "Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients." Neurol Res 28(3): 262-269. [Open article]

2005

  • Frohman EM, Stuve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, Sorensen PS, Phillips JT, Weinshenker B, Hawker K, Hartung HP, Steinman L, Zamvil S, Cree BA, Hauser S, Weiner H, Racke MK and Filippi M (2005). "Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations." Arch Neurol 62(10): 1519-1530. [Open article]
  • Zivadinov R (2005). "Steroids and brain atrophy in multiple sclerosis." J Neurol Sci 233(1-2): 73-81. [Open article]
  • Zorzon M, Zivadinov R, Locatelli L, Giuntini D, Toncic M, Bosco A, Nasuelli D, Bratina A, Tommasi MA, Rudick RA and Cazzato G (2005). "Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis." Eur J Neurol 12(7): 550-556. [Open article]
  • Zivadinov R, Grop A, Sharma J, Bratina A, Tjoa CW, Dwyer M and Zorzon M (2005). "Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis." J Neuroimaging 15(1): 27-36. [Open article]
  • Benedict RH, Zivadinov R, Carone DA, Weinstock-Guttman B, Gaines J, Maggiore C, Sharma J, Tomassi MA and Bakshi R (2005). "Regional lobar atrophy predicts memory impairment in multiple sclerosis." AJNR Am J Neuroradiol 26(7): 1824-1831. [Open article]
  • Benedict RH, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R and Weinstock-Guttman B (2005). "Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change." J Neurol Sci 231(1-2): 29-34. [Open article]
  • Zivadinov R and Leist TP (2005). "Clinical-magnetic resonance imaging correlations in multiple sclerosis." J Neuroimaging 15(4 Suppl): 10S-21S. [Open article]

2004

  • Fishman I, Benedict RH, Bakshi R, Priore R and Weinstock-Guttman B (2004). "Construct validity and frequency of euphoria sclerotica in multiple sclerosis." J Neuropsychiatry Clin Neurosci 16(3): 350-356. [Open article]
  • Locatelli L, Zivadinov R, Grop A and Zorzon M (2004). "Frontal parenchymal atrophy measures in multiple sclerosis." Mult Scler 10(5): 562-568. [Open article]
  • Santa Maria MP, Benedict RH, Bakshi R, Coad ML, Wack D, Burkard R, Weinstock-Guttman B, Roberts S and Lockwood AH (2004). "Functional imaging during covert auditory attention in multiple sclerosis." J Neurol Sci 218(1-2): 9-15. [Open article]
  • Sharma J, Sanfilipo MP, Benedict RH, Weinstock-Guttman B, Munschauer FE, 3rd and Bakshi R (2004). "Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation." AJNR Am J Neuroradiol 25(6): 985-996. [Open article]
  • Zivadinov R and Sepcic J (2004). "[Cognitive impairment in multiple sclerosis patients]." Lijec Vjesn 126(7-8): 204-210. [Open article]
  • Bagnato F, Zivadinov R, Cecchinelli D, Tancredi A, Grop A, Pierallini A, De Lena C, Prencipe M, Reale G, Zorzon M and Millefiorini E (2004). "beta2-microglobulin serum level is not a marker of disease activity in multiple sclerosis." Eur J Neurol 11(7): 455-460. [Open article]
  • Benedict RH, Carone DA and Bakshi R (2004). "Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis." J Neuroimaging 14(3 Suppl): 36S-45S. [Open article]
  • Fiotti N, Zivadinov R, Altamura N, Nasuelli D, Bratina A, Tommasi MA, Bosco A, Locatelli L, Grop A, Cazzato G, Guarnieri G, Giansante C and Zorzon M (2004). "MMP-9 microsatellite polymorphism and multiple sclerosis." J Neuroimmunol 152(1-2): 147-153. [Open article]
  • Zivadinov R and Bakshi R (2004). "Central nervous system atrophy and clinical status in multiple sclerosis." J Neuroimaging 14(3 Suppl): 27S-35S. [Open article]
  • Zivadinov R and Bakshi R (2004). "Role of MRI in multiple sclerosis II: brain and spinal cord atrophy." Front Biosci 9: 647-664. [Open article]
  • Zivadinov R and Bakshi R (2004). "Role of MRI in multiple sclerosis I: inflammation and lesions." Front Biosci 9: 665-683. [Open article]
  • Shucard JL, Parrish J, Shucard DW, McCabe DC, Benedict RH and Ambrus J, Jr. (2004). "Working memory and processing speed deficits in systemic lupus erythematosus as measured by the paced auditory serial addition test." J Int Neuropsychol Soc 10(1): 35-45. [Open article]
  • Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW and Bakshi R (2004). "Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden." Arch Neurol 61(2): 226-230. [Open article]
  • Ionita C, Wasay M, Balos L and Bakshi R (2004). "MR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease." AJNR Am J Neuroradiol 25(2): 270-273. [Open article]
  • Zivadinov R, Bagnato F, Nasuelli D, Bastianello S, Bratina A, Locatelli L, Watts K, Finamore L, Grop A, Dwyer M, Catalan M, Clemenzi A, Millefiorini E, Bakshi R and Zorzon M (2004). "Short-term brain atrophy changes in relapsing-remitting multiple sclerosis." J Neurol Sci 223(2): 185-193. [Open article]
  • Sanfilipo MP, Benedict RH, Zivadinov R and Bakshi R (2004). "Correction for intracranial volume in analysis of whole brain atrophy in multiple sclerosis: the proportion vs. residual method." Neuroimage 22(4): 1732-1743. [Open article]
  • Weinstock-Guttman B and Bakshi R (2004). "Combination therapy for multiple sclerosis: the treatment strategy of the future?" CNS Drugs 18(12): 777-792. [Open article]

2003

  • Zivadinov R, Uxa L, Zacchi T, Nasuelli D, Ukmar M, Furlan C, Pozzi-Mucelli R, Tommasi MA, Locatelli L, Ulivi S, Bratina A, Bosco A, Grop A, Cazzato G and Zorzon M (2003). "HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis." J Neurol 250(9): 1099-1106. [Open article]
  • Fabiano AJ, Sharma J, Weinstock-Guttman B, Munschauer FE, 3rd, Benedict RH, Zivadinov R and Bakshi R (2003). "Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study." J Neuroimaging 13(4): 307-314. [Open article]
  • Zivadinov R, Locatelli L, Stival B, Bratina A, Grop A, Nasuelli D, Brnabic-Razmilic O and Zorzon M (2003). "Normalized regional brain atrophy measurements in multiple sclerosis." Neuroradiology 45(11): 793-798. [Open article]
  • Zorzon M, Zivadinov R, Nasuelli D, Dolfini P, Bosco A, Bratina A, Tommasi MA, Locatelli L and Cazzato G (2003). "Risk factors of multiple sclerosis: a case-control study." Neurol Sci 24(4): 242-247. [Open article]
  • Bermel RA, Innus MD, Tjoa CW and Bakshi R (2003). "Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study." Neuroreport 14(3): 335-339. [Open article]
  • Zivadinov R, Zorzon M, Locatelli L, Stival B, Monti F, Nasuelli D, Tommasi MA, Bratina A and Cazzato G (2003). "Sexual dysfunction in multiple sclerosis: a MRI, neurophysiological and urodynamic study." J Neurol Sci 210(1-2): 73-76. [Open article]
  • Bakshi R (2003). "Fatigue associated with multiple sclerosis: diagnosis, impact and management." Mult Scler 9(3): 219-227. [Open article]
  • Weinstock-Guttman B, Jacobs LD, Brownscheidle CM, Baier M, Rea DF, Apatoff BR, Blitz KM, Coyle PK, Frontera AT, Goodman AD, Gottesman MH, Herbert J, Holub R, Lava NS, Lenihan M, Lusins J, Mihai C, Miller AE, Perel AB, Snyder DH, Bakshi R, Granger CV, Greenberg SJ, Jubelt B, Krupp L, Munschauer FE, Rubin D, Schwid S, Smiroldo J and New York State Multiple Sclerosis C (2003). "Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium." Mult Scler 9(3): 293-298. [Open article]
  • Zhang LX, Bakshi R, Fine E and Moser HW (2003). "Clinical and electrophysiological improvement of adrenomyeloneuropathy with steroid treatment." J Neurol Neurosurg Psychiatry 74(6): 822-823. [Open article]
  • Zivadinov R, Willheim K, Sepic-Grahovac D, Jurjevic A, Bucuk M, Brnabic-Razmilic O, Relja G and Zorzon M (2003). "Migraine and tension-type headache in Croatia: a population-based survey of precipitating factors." Cephalalgia 23(5): 336-343. [Open article]
  • Bakshi R, Alexandrov AV, Gomez CR and Masdeu JC (2003). "Neuroimaging curriculum for neurology trainees: report from the Neuroimaging Section of the AAN." J Neuroimaging 13(3): 215-217. [Open article]
  • Wasay M, Kheleani BA, Moolani MK, Zaheer J, Pui M, Hasan S, Muzaffar S, Bakshi R and Sarawari AR (2003). "Brain CT and MRI findings in 100 consecutive patients with intracranial tuberculoma." J Neuroimaging 13(3): 240-247. [Open article]
  • Zivadinov R, Iona L, Monti-Bragadin L, Bosco A, Jurjevic A, Taus C, Cazzato G and Zorzon M (2003). "The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study." Neuroepidemiology 22(1): 65-74. [Open article]
  • Kuperan S, Ostrow P, Landi MK and Bakshi R (2003). "Acute hemorrhagic leukoencephalitis vs ADEM: FLAIR MRI and neuropathology findings." Neurology 60(4): 721-722. [Open article]
  • Benedict RH, Munschauer F, Linn R, Miller C, Murphy E, Foley F and Jacobs L (2003). "Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire." Mult Scler 9(1): 95-101. [Open article]
  • Zorzon M, Zivadinov R, Locatelli L, Stival B, Nasuelli D, Bratina A, Bosco A, Tommasi MA, Pozzi Mucelli RS, Ukmar M and Cazzato G (2003). "Correlation of sexual dysfunction and brain magnetic resonance imaging in multiple sclerosis." Mult Scler 9(1): 108-110. [Open article]
  • Susac JO, Murtagh FR, Egan RA, Berger JR, Bakshi R, Lincoff N, Gean AD, Galetta SL, Fox RJ, Costello FE, Lee AG, Clark J, Layzer RB and Daroff RB (2003). "MRI findings in Susac's syndrome." Neurology 61(12): 1783-1787. [Open article]
  • Horsfield MA, Rovaris M, Rocca MA, Rossi P, Benedict RH, Filippi M and Bakshi R (2003). "Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences." J Neurol Sci 216(1): 169-177. [Open article]
  • Zivadinov R, Zorzon M, Tommasi MA, Nasuelli D, Bernardi M, Monti-Bragadin L and Cazzato G (2003). "A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a." J Neurol Sci 216(1): 113-118. [Open article]
  • Benedict RH, Fishman I, McClellan MM, Bakshi R and Weinstock-Guttman B (2003). "Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis." Mult Scler 9(4): 393-396. [Open article]
  • Bermel RA, Sharma J, Tjoa CW, Puli SR and Bakshi R (2003). "A semiautomated measure of whole-brain atrophy in multiple sclerosis." J Neurol Sci 208(1-2): 57-65. [Open article]
  • Xavier AR, Qureshi AI, Kirmani JF, Yahia AM and Bakshi R (2003). "Neuroimaging of stroke: a review." South Med J 96(4): 367-379. [Open article]

2002

  • Benedict RH, Bakshi R, Simon JH, Priore R, Miller C and Munschauer F (2002). "Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis." J Neuropsychiatry Clin Neurosci 14(1): 44-51. [Open article]
  • Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Kooijmans MF, Sandrock AW, Rudick RA, Simon JH, Simonian NA, Tsao EC, Whitaker JN and Investigators I (2002). "Benefit of interferon beta-1a on MSFC progression in secondary progressive MS." Neurology 59(5): 679-687. [Open article]
  • Zorzon M, Zivadinov R, Nasuelli D, Ukmar M, Bratina A, Tommasi MA, Mucelli RP, Brnabic-Razmilic O, Grop A, Bonfigli L and Cazzato G (2002). "Depressive symptoms and MRI changes in multiple sclerosis." Eur J Neurol 9(5): 491-496. [Open article]
  • Zivadinov R and Zorzon M (2002). "Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature." J Neuroimaging 12(4): 302-309. [Open article]
  • Benedict RH, Shucard DW, Santa Maria MP, Shucard JL, Abara JP, Coad ML, Wack D, Sawusch J and Lockwood A (2002). "Covert auditory attention generates activation in the rostral/dorsal anterior cingulate cortex." J Cogn Neurosci 14(4): 637-645. [Open article]
  • Bhojo AK, Akhter N, Bakshi R and Wasay M (2002). "Thoracic myelopathy complicating acute meningococcal meningitis: MRI findings." Am J Med Sci 323(5): 263-265. [Open article]
  • Wasay M, Bakshi R, Bobustuc G, Dubey N, Cheema Z and Dai A (2002). "Diffusion-weighted magnetic resonance imaging in superior sagittal sinus thrombosis." J Neuroimaging 12(3): 267-269. [Open article]
  • Bakshi R, Benedict RH, Bermel RA, Caruthers SD, Puli SR, Tjoa CW, Fabiano AJ and Jacobs L (2002). "T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study." Arch Neurol 59(1): 62-68. [Open article]
  • Giglio P, Bakshi R, Block S, Ostrow P and Pullicino PM (2002). "Primary central nervous system lymphoma masquerading as herpes encephalitis: clinical, magnetic resonance imaging, and pathologic findings." Am J Med Sci 323(1): 59-61. [Open article]
  • Weinstock A, Giglio P, Cohen ME, Bakshi R, Januario J and Balos L (2002). "Diffuse magnetic resonance imaging white-matter changes in a 15-year-old boy with mitochondrial encephalomyopathy." J Child Neurol 17(1): 47-49. [Open article]
  • Bermel RA, Bakshi R, Tjoa C, Puli SR and Jacobs L (2002). "Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis." Arch Neurol 59(2): 275-280. [Open article]
  • Zorzon M, Capus L, Pellegrino A, Cazzato G and Zivadinov R (2002). "Familial and environmental risk factors in Parkinson's disease: a case-control study in north-east Italy." Acta Neurol Scand 105(2): 77-82. [Open article]
  • Dubey N, Miletich RS, Wasay M, Mechtler LL and Bakshi R (2002). "Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis." J Neurol Sci 205(1): 77-81. [Open article]
  • Janardhan V and Bakshi R (2002). "Quality of life in patients with multiple sclerosis: the impact of fatigue and depression." J Neurol Sci 205(1): 51-58. [Open article]
  • Benedict RH, Fischer JS, Archibald CJ, Arnett PA, Beatty WW, Bobholz J, Chelune GJ, Fisk JD, Langdon DW, Caruso L, Foley F, LaRocca NG, Vowels L, Weinstein A, DeLuca J, Rao SM and Munschauer F (2002). "Minimal neuropsychological assessment of MS patients: a consensus approach." Clin Neuropsychol 16(3): 381-397. [Open article]
  • Murthy SN, Faden HS, Cohen ME and Bakshi R (2002). "Acute disseminated encephalomyelitis in children." Pediatrics 110(2 Pt 1): e21. [Open article]

2001

  • Benedict RH, Priore RL, Miller C, Munschauer F and Jacobs L (2001). "Personality disorder in multiple sclerosis correlates with cognitive impairment." J Neuropsychiatry Clin Neurosci 13(1): 70-76. [Open article]
  • Zivadinov R, Willheim K, Jurjevic A, Sepic-Grahovac D, Bucuk M and Zorzon M (2001). "Prevalence of migraine in Croatia: a population-based survey." Headache 41(8): 805-812. [Open article]
  • Zivadinov R, Rudick RA, De Masi R, Nasuelli D, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G and Zorzon M (2001). "Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS." Neurology 57(7): 1239-1247. [Open article]
  • Wasay M, Bakshi R, Kojan S, Bobustuc G, Dubey N and Unwin DH (2001). "Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis." Stroke 32(10): 2310-2317. [Open article]
  • Wong EH, Pullicino PM and Benedict R (2001). "Deep cerebral infarcts extending to the subinsular region." Stroke 32(10): 2272-2277. [Open article]
  • Block SA and Bakshi R (2001). "FLAIR MRI of striatonigral degeneration." Neurology 56(9): 1200. [Open article]
  • Bakshi R, Ariyaratana S, Benedict RH and Jacobs L (2001). "Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions." Arch Neurol 58(5): 742-748. [Open article]
  • Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, Bratina A and Zivadinov R (2001). "Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects." J Neurol 248(5): 416-421. [Open article]
  • Bakshi R, Dmochowski J, Shaikh ZA and Jacobs L (2001). "Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients." J Neurol Sci 185(1): 19-26. [Open article]
  • Zorzon M, Zivadinov R, Monti Bragadin L, Moretti R, De Masi R, Nasuelli D and Cazzato G (2001). "Sexual dysfunction in multiple sclerosis: a 2-year follow-up study." J Neurol Sci 187(1-2): 1-5. [Open article]
  • Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Jak AJ, Kniker JE, Kooijmans MF, Lull JM, Sandrock AW, Simon JH, Simonian NA and Whitaker JN (2001). "Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial." Arch Neurol 58(6): 961-967. [Open article]
  • Moretti R, Bava A, Torre P, Antonello RM, Zorzon M, Zivadinov R and Cazzato G (2001). "Bilingual aphasia and subcortical-cortical lesions." Percept Mot Skills 92(3 Pt 1): 803-814. [Open article]
  • Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, Tommasi MA, Zambito-Marsala S, Moretti R, Bratina A, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G and Zorzon M (2001). "A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis." J Neurol Neurosurg Psychiatry 70(6): 773-780. [Open article]
  • Bakshi R, Lerner A, Fritz JV and Sambuchi GD (2001). "Vascular compression in trigeminal neuralgia shown by magnetic resonance imaging and magnetic resonance angiography image registration." Arch Neurol 58(8): 1290-1291. [Open article]
  • Bakshi R (2001). "Solitary inflammatory demyelination in the brain or spinal cord with tumor-like MRI presentations." Arch Neurol 58(4): 677. [Open article]
  • Bakshi R, Benedict RH, Bermel RA and Jacobs L (2001). "Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings." J Neuroimaging 11(2): 129-136. [Open article]
  • Dubey N, Bakshi R, Wasay M and Dmochowski J (2001). "Early computed tomography hypodensity predicts hemorrhage after intravenous tissue plasminogen activator in acute ischemic stroke." J Neuroimaging 11(2): 184-188. [Open article]
  • Zivadinov R, De Masi R, Nasuelli D, Bragadin LM, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G and Zorzon M (2001). "MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis." Neuroradiology 43(4): 272-278. [Open article]

2000

  • Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ and Sandrock AW (2000). "Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group." N Engl J Med 343(13): 898-904. [Open article]
  • Block SA, Bakshi R, Kuritzky P and Kinkel WR (2000). "Hemodynamic changes in simple partial epilepsy: a functional MRI study." Neurology 55(5): 737-738. [Open article]
  • Bakshi R, Morcos MF, Gabryel TF and Dandona P (2000). "Is fluid-attenuated inversion recovery MRI more sensitive than conventional MRI for hypoglycemic brain injury?" Neurology 55(7): 1064-1065. [Open article]
  • Janardhan V and Bakshi R (2000). "Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis." Arch Neurol 57(10): 1485-1491. [Open article]
  • Shaikh ZA, Bakshi R, Wasay M, Dai A and Gosy E (2000). "Magnetic resonance imaging findings in bilateral Bell's palsy." J Neuroimaging 10(4): 223-225. [Open article]
  • Bakshi R (2000). "Diffusion-weighted MRI as an evolving standard of care in acute stroke." Neurology 55(10): 1595. [Open article]
  • Dai A, Wasay M, Dubey N, Giglio P and Bakshi R (2000). "Superior sagittal sinus thrombosis secondary to hyperthyroidism." J Stroke Cerebrovasc Dis 9(2): 89-90. [Open article]
  • Bakshi R, Caruthers SD, Janardhan V and Wasay M (2000). "Intraventricular CSF pulsation artifact on fast fluid-attenuated inversion-recovery MR images: analysis of 100 consecutive normal studies." AJNR Am J Neuroradiol 21(3): 503-508. [Open article]
  • Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K, Janardhan V, Dubey N and Kinkel PR (2000). "Fatigue in multiple sclerosis and its relationship to depression and neurologic disability." Mult Scler 6(3): 181-185. [Open article]
  • Kamran S, Bates V, Bakshi R, Wright P, Kinkel W and Miletich R (2000). "Significance of hyperintense vessels on FLAIR MRI in acute stroke." Neurology 55(2): 265-269. [Open article]
  • Shaikh ZA, Bakshi R, Greenberg SJ, Fine EJ, Shatla A and Lincoff NS (2000). "Orbital involvement as the initial manifestation of sarcoidosis: magnetic resonance imaging findings." J Neuroimaging 10(3): 180-183. [Open article]
  • Wasay M, Bakshi R, Kojan S, Bobustuc G and Dubey N (2000). "Superior sagittal sinus thrombosis due to lithium: local urokinase thrombolysis treatment." Neurology 54(2): 532-533. [Open article]
  • Bakshi R, Shaikh ZA and Janardhan V (2000). "MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation." Neuroreport 11(1): 15-21. [Open article]
  • Benedict RH, Shapiro A, Priore R, Miller C, Munschauer F and Jacobs L (2000). "Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients." Mult Scler 6(6): 391-396. [Open article]
  • Zorzon M, Ukmar M, Bragadin LM, Zanier F, Antonello RM, Cazzato G and Zivadinov R (2000). "Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: a clinical and MR study." Mult Scler 6(6): 386-390. [Open article]
  • Benedict RH, Mezhir JJ, Walsh K and Hewitt RG (2000). "Impact of human immunodeficiency virus type-1-associated cognitive dysfunction on activities of daily living and quality of life." Arch Clin Neuropsychol 15(6): 535-544. [Open article]
  • Bakshi R, Czarnecki D, Shaikh ZA, Priore RL, Janardhan V, Kaliszky Z and Kinkel PR (2000). "Brain MRI lesions and atrophy are related to depression in multiple sclerosis." Neuroreport 11(6): 1153-1158. [Open article]

1999

  • Zivadinov R, Zorzon M, Monti Bragadin L, Pagliaro G and Cazzato G (1999). "Olfactory loss in multiple sclerosis." J Neurol Sci 168(2): 127-130. [Open article]
  • Cazzato G, Antonello RM, Zorzon M, Torre P, Zivadinov R, Moretti R, Bragadin LM, De Masi R and Nasuelli D (1999). "[Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis]." Recenti Prog Med 90(10): 538-544. [Open article]
  • Zivadinov R, Zorzon M, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Iona LG and Cazzato G (1999). "Sexual dysfunction in multiple sclerosis: II. Correlation analysis." Mult Scler 5(6): 428-431. [Open article]
  • Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Morassi P, Iona LG and Cazzato G (1999). "Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups." Mult Scler 5(6): 418-427. [Open article]

1998

  • Zivadinov R, Jurjevic A, Willheim K, Cazzato G and Zorzon M (1998). "Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996." Neuroepidemiology 17(5): 265-272. [Open article]